• Pharmacovigilance World 2024 - This conference will serve as a knowledge-sharing and networking platform, providing a unique opportunity for researchers, pharmacists, healthcare professionals, industry representatives, and regulatory authorities to come together and discuss the latest trends, challenges, and advancements in pharmacovigilance. By sharing experiences and best practices, we aim to enhance global drug safety and improve patient outcomes. Throughout the conference, we will delve into various topics such as signal detection and management, adverse event reporting and analysis, risk assessment, benefit-risk evaluation, regulatory updates, collaboration and the integration of artificial intelligence and digital technologies in pharmacovigilance. Our esteemed panel of speakers, comprising leading experts from academia, industry, and regulatory agencies, will present their research findings, share case studies, and engage in thought-provoking discussions. The conference will also feature interactive networking opportunities, fostering collaboration and enabling the exchange of ideas. We are delighted to welcome you to the Pharmacovigilance World 2024, and we are confident that your active participation will contribute to the advancement of drug safety practices. Together, let us strive towards a safer and more vigilant healthcare system that prioritizes patient well-being and ensures the continued benefit of medications worldwide. Key Highlights: Pharmacovigilance and globalization Pharmacovigilance in a pandemic world Women and child health care medicines and pharmacovigilance Patient-centric approaches in PV Pharmacovigilance legislation and regulations Harmonization and pharmacovigilance Advanced therapeutic techniques and pharmacovigilance Pharmacovigilance and data management and eudravigilance Post-marketing surveillance in pharmacovigilance PV regulations and challenges Benefit-risk management strategies Risk management and minimization Risk Evaluation and Mitigation Adverse drug reactions reporting Signal detection and post authorization safety Good Pharmacovigilance Practices Innovative approaches to drug safety Strategies to improve PV Real World Evidence in PV Big data and AI in pharmacovigilance Pharmacovigilance Workflows with AI & Automation Other emerging technologies in PV Who should attend the conference? Attendees include GMs, VPs, Directors, Heads and Managers of: Pharmacovigilance Safety & Risk management Drug safety PV Compliance Safety Surveillance Medical Affairs Regulatory Affairs Inspection and Audit Pharmacoepidemiology Post-market studies Medical product safety assessment Drug Research & Development Clinical Pharmacology Medical information Contract outsourcing service providers Health outcomes Sales and Marketing (Added: Sat Mar 30 2024 Hits: 56 Rating: 0.00 Votes: 0) Rate It

• Pharmacovigilance World 2024 - This conference will serve as a knowledge-sharing and networking platform, providing a unique opportunity for researchers, pharmacists, healthcare professionals, industry representatives, and regulatory authorities to come together and discuss the latest trends, challenges, and advancements in pharmacovigilance. By sharing experiences and best practices, we aim to enhance global drug safety and improve patient outcomes. Throughout the conference, we will delve into various topics such as signal detection and management, adverse event reporting and analysis, risk assessment, benefit-risk evaluation, regulatory updates, collaboration and the integration of artificial intelligence and digital technologies in pharmacovigilance. Our esteemed panel of speakers, comprising leading experts from academia, industry, and regulatory agencies, will present their research findings, share case studies, and engage in thought-provoking discussions. The conference will also feature interactive networking opportunities, fostering collaboration and enabling the exchange of ideas. We are delighted to welcome you to the Pharmacovigilance World 2024, and we are confident that your active participation will contribute to the advancement of drug safety practices. Together, let us strive towards a safer and more vigilant healthcare system that prioritizes patient well-being and ensures the continued benefit of medications worldwide. Key Highlights: Pharmacovigilance and globalization Pharmacovigilance in a pandemic world Women and child health care medicines and pharmacovigilance Patient-centric approaches in PV Pharmacovigilance legislation and regulations Harmonization and pharmacovigilance Advanced therapeutic techniques and pharmacovigilance Pharmacovigilance and data management and eudravigilance Post-marketing surveillance in pharmacovigilance PV regulations and challenges Benefit-risk management strategies Risk management and minimization Risk Evaluation and Mitigation Adverse drug reactions reporting Signal detection and post authorization safety Good Pharmacovigilance Practices Innovative approaches to drug safety Strategies to improve PV Real World Evidence in PV Big data and AI in pharmacovigilance Pharmacovigilance Workflows with AI & Automation Other emerging technologies in PV Who should attend the conference? Attendees include GMs, VPs, Directors, Heads and Managers of: Pharmacovigilance Safety & Risk management Drug safety PV Compliance Safety Surveillance Medical Affairs Regulatory Affairs Inspection and Audit Pharmacoepidemiology Post-market studies Medical product safety assessment Drug Research & Development Clinical Pharmacology Medical information Contract outsourcing service providers Health outcomes Sales and Marketing (Added: Sat Mar 30 2024 Hits: 52 Rating: 0.00 Votes: 0) Rate It

• Pharmacovigilance World 2024 - This conference will serve as a knowledge-sharing and networking platform, providing a unique opportunity for researchers, pharmacists, healthcare professionals, industry representatives, and regulatory authorities to come together and discuss the latest trends, challenges, and advancements in pharmacovigilance. By sharing experiences and best practices, we aim to enhance global drug safety and improve patient outcomes. Throughout the conference, we will delve into various topics such as signal detection and management, adverse event reporting and analysis, risk assessment, benefit-risk evaluation, regulatory updates, collaboration and the integration of artificial intelligence and digital technologies in pharmacovigilance. Our esteemed panel of speakers, comprising leading experts from academia, industry, and regulatory agencies, will present their research findings, share case studies, and engage in thought-provoking discussions. The conference will also feature interactive networking opportunities, fostering collaboration and enabling the exchange of ideas. We are delighted to welcome you to the Pharmacovigilance World 2024, and we are confident that your active participation will contribute to the advancement of drug safety practices. Together, let us strive towards a safer and more vigilant healthcare system that prioritizes patient well-being and ensures the continued benefit of medications worldwide. Key Highlights: Pharmacovigilance and globalization Pharmacovigilance in a pandemic world Women and child health care medicines and pharmacovigilance Patient-centric approaches in PV Pharmacovigilance legislation and regulations Harmonization and pharmacovigilance Advanced therapeutic techniques and pharmacovigilance Pharmacovigilance and data management and eudravigilance Post-marketing surveillance in pharmacovigilance PV regulations and challenges Benefit-risk management strategies Risk management and minimization Risk Evaluation and Mitigation Adverse drug reactions reporting Signal detection and post authorization safety Good Pharmacovigilance Practices Innovative approaches to drug safety Strategies to improve PV Real World Evidence in PV Big data and AI in pharmacovigilance Pharmacovigilance Workflows with AI & Automation Other emerging technologies in PV Who should attend the conference? Attendees include GMs, VPs, Directors, Heads and Managers of: Pharmacovigilance Safety & Risk management Drug safety PV Compliance Safety Surveillance Medical Affairs Regulatory Affairs Inspection and Audit Pharmacoepidemiology Post-market studies Medical product safety assessment Drug Research & Development Clinical Pharmacology Medical information Contract outsourcing service providers Health outcomes Sales and Marketing (Added: Sat Mar 30 2024 Hits: 52 Rating: 0.00 Votes: 0) Rate It

• 15th American Healthcare, - We cordially invite you to attend the "15th American Healthcare, Hospital management, Nursing, And Patient Safety Summit; (15AHNPSUCG2025)," which will be conducted from May 14-16 as a hybrid event in San Francisco, United States & Virtual. The primary focus of the conference will be “Facilitate the exchange of the latest research findings, best practices, and innovations in healthcare and nursing...” Medical professional consultations, interactive lectures by lecturers from across the world, and quick condition diagnosis are all included. You can benefit from the knowledge and experience of seasoned specialists in the medical field, cosmetic medicine, production and distribution of professional products and equipment for medical centres, and other related fields. This event will focus on the strategies and practices that enable healthcare leaders to remain resilient and respond successfully in periods of sustained crisis and brings together information and technology professionals, healthcare executives and clinicians, consultants, entrepreneurs, and market suppliers from around the world. Attendees can expect to explore topics such as Healthcare, Nursing, Hospital, Management, Nursing, Patient Safety, Mental Health, Telenursing, Artificial Intelligence, Medication Safety, Pharmaceuticals, and Healthcare Innovations & Quality Improvement. Looking for the documents required to avail USA Visa? Questions asked during the USA Visa Interview? Process of USA Visa? Not getting USA? Visa Appointment? Need an Invitation Letter? 15th American Healthcare, Hospital management, Nursing, And Patient Safety Summit brings together experts in the worldwide business, up-and-coming fast-growing companies, new technology inventors, and members of the investment community. It is the largest and most educational health care investment symposium in the sector. Bothered about USA Visa? We are here to assist you in applying for a visa. We will guide you through the visa process once you have registered as a speaker/listener/poster. The visa will be valid for 5-10 years. Why San Francisco? San Francisco is wellknown for the Golden Gate Bridge, its steep streets, Alcatraz, and - you guessed it, dude! - Full HouseThe thirteenth largest city in the United States is also home to several fascinating historical facts.The city is recognised for its steep rolling hills, eclectic mix of architecture throughout diverse neighbourhoods, chilly summers, fog, and sights such as the Golden Gate Bridge, cable cars, Alcatraz, and the Chinatown and Mission districts. Our Previous Conference Speakers: Dr. Barbara De Groot- Doctor of Nursing Practice Mr. Charles Hale - Founder and President of Hale Consulting Solutions LLC Mr. Sergey Sergyenko - CEO of Cybergizer Prof. Frank Chindamo - Founder & Chief Creative Officer, LaughMD Dr. Barry Lachman - President and CEO at Lachman Community Development and ConsultingServices Ms. Sue E. Goodin - CEO, ResilienceONE Prof. Robert H. Schiestl - UCLA Center of Occupational and Environmental Health Ms. Lori Beth Irvin - Founder & CEO | LBIngenuity Mr. David M. Zechman, President, The Zechman Group, and CEO of Mergestone Group Our previous and upcoming speakers and committee members: https://health.universeconferences.com/committee-members-and-speakers/ To know more visit our past report: https://health.universeconferences.com/15th-american-healthcare-hospital-management-nursing-and-patient-safety-summit/ 11th American Healthcare Summit 2022, San Francisco, USA Speakers:- Ms. Laurin Mooney from USA, DR. Claire Sorenson from USA, Ms. Leann Thieman from USA, Ms. Janelle Ali-Dinar from USA, Dr. Fernando Carvalho, Dr. Jeffrey L. Gurian, Ms. Karen D. Walker, Ms. Anhar Ali Alherz( UAE), Dr. M Health Corner, Dr. Unati Makiwane from Alberta, Mr. Jon Melton from USA To know more visit our past report: https://health.universeconferences.com/11th-american-healthcare-summit-2022-san-francisco-usa/ CALL FOR ABSTRACT IS OPEN! Primary Healthcare, Hospital Management, Mental Health and Behaviour, Metabolic Problems, Child health Poisoning, Toxicology, Environmental Health, Coronavirus disease (COVID-19), Global health ethics, Health economics, Health Equity, Health impact assessment, Adolescent health, Brain health, Health promotion, Substandard and falsified medical products, Universal Health Coverage, Urban health Vaccines and immunization. To know more about topics visit: Important Updates; Group Discount is Available (5+Members) The 15th American Healthcare, Hospital management, Nursing, And Patient Safety Summit attract over 1000+ attendees every year. Submit your Proposal to speak at an in-person conference event today Email: health@ucgconferences.com Important Information: Conference Name: 15th American Healthcare, Hospital Management, Nursing, And Patient Safety Summit Short Name: #15AHNPSUCG2025 Dates: May 14-16,2025 Venue: San Francisco, United States & Virtual Email: health@ucgconferences.com Visit: https://health.universeconferences.com/ Call for Papers: https://health.universeconferences.com/call-for-paper/ Register here: https://health.universeconferences.com/registration/ Call/WhatsApp Us: +442033222718 Target Audience; Front-Line Staff, Officers, Directors, Vice-Presidents, C-Level Executives, Physicians, Nurses, Medical Assistants, Pharmacists, Professors, Researchers, Policy Makers, Consultants, Patient Advocates, Chief Executive/Director/Associate Director/Assistant Director/Chief/Chair/Non-Clinical Director/Medical Director. Clinical Lead/Senior Clinical Health Practitioner/Head Of Clinical Service Delivery, Consultant/Senior Consultant/ /Consultant Anaesthetist, Doctor, Surgeon, Head Of Education And Training/Clinical Lead For Training And Development/Director Of Hr, Education And Training, Head Of Clinical Governance/Governance And Risk Manager/Clinical Governance And Reporting Manager, Head Of Nursing/Director Of Healthcare. AmericanNHPSUCG2025-SUPPORTING JOURNALS Unified Citation Journals is a platform for the latest discoveries in Technology, Science, engineering, medicine, medical clinical, and advancing discoveries and health. We at Unified Citation Journals ensure the advancement of healthcare and improve performance for the benefit of humanity. Unified Citation Journals empower and publish scientific research work. We will be including special issues and symposia papers in related journals from all over the world. Apart from publishing, we also promote upcoming books covering different fields of science, medicine, engineering, technology, etc. Unified Citation Journals help Authors, Publishers, and Distributors, in growing their business multifold. Social Media https://www.facebook.com/profile.php?id=100081786931096 https://www.instagram.com/healthcareucgconferences/ https://www.reddit.com/user/HMSUCG2021 https://www.tumblr.com/ https://twitter.com/HealthcareUCG https://www.linkedin.com/in/dr-rahma-taher-saleh-b3990b23b/ https://www.quora.com/profile/Dr-Rahma-Taher-Saleh https://mewe.com/i/healthcareucgconferences https://in.pinterest.com/ https://www.xing.com/profile/DrRahmaTaher_Saleh/cv https://www.youtube.com/shorts/oskSEoX2CDI More details: https://ucjournals.com/ Submit your e-posters today! Poster Community is a medium of electronic presentation of your scientific posters that allow you to present and publish the latest scientific research work of your interest in front of worldwide viewers, learners, and open access community. A poster is worth a thousand words; it’s self-explanatory – it stands on its own and does most of your explanation digitally. We welcome researchers to submit their posters and make it visible. Posters can contain many different rich resources such as research work, case reports, presentations, company profiles, assignments, images, trending news, projects, summary, results, apps, links, etc. More details: https://eposters.universeconferences.com/ ------------------------------ Community: Utilitarian Conferences Gathering Reg. No. 12330203 Registered at UCG, 12 Constance Street, London, England, E16 2DQ, UK Utilitarian Conferences Gathering, Company Reg. No. 12330203 Utilitarian Conferences Gathering offers a wide range of events, Meetings, Conferences, Workshops, symposiums. We have a dedicated team who are aimed at acquiring the technologies, adopting the knowledge of business needs, and accelerating with the best ideas and strategies. Utilitarian Conferences Gathering is a pioneer in the area of Event Management, Collaboration. We are a full-service event provider specializing in the field of Medical, Clinical, Healthcare, Life Sciences, Engineering, Pharma, Environmental Science, Engineering, Business, Agricultural, and Food event services for Academic and Industrial Sectors. We stand out distinctively from our competitors for our commitment to quality, round-the-clock service, and unmatched price. We are able to provide you with the best event, Meeting experience under one roof. We at Utilitarian Conferences Gathering make sure that you as a client choose the most appropriate event. More Information: https://universeconferences.com/ https://twitter.com/UCGConferences Facebook: https://www.facebook.com/utilitarianconferences.gathering.7 ----------------------------------- #AmericanHealthcareconference2025 #Hospitalmanagementsummit #healthcare #health #primaryhealth #nursing #patientsafety #healthcaremanagement #patientcare #occupationalhealth #healthsystem #pharmaceutical #clinicaltrials #diabetes #changemanagement #mentalhealth #familyplanning #ACP #Infectionprevention #telehealth #oralhealth #Healthcareconference (Added: Sat Mar 30 2024 Hits: 57 Rating: 0.00 Votes: 0) Rate It

• 15th American Healthcare, Hospital management, Nursing, And Patient Safety Summit - We cordially invite you to attend the "15th American Healthcare, Hospital management, Nursing, And Patient Safety Summit; (15AHNPSUCG2025)," which will be conducted from May 14-16 as a hybrid event in San Francisco, United States & Virtual. The primary focus of the conference will be “Facilitate the exchange of the latest research findings, best practices, and innovations in healthcare and nursing...” Medical professional consultations, interactive lectures by lecturers from across the world, and quick condition diagnosis are all included. You can benefit from the knowledge and experience of seasoned specialists in the medical field, cosmetic medicine, production and distribution of professional products and equipment for medical centres, and other related fields. This event will focus on the strategies and practices that enable healthcare leaders to remain resilient and respond successfully in periods of sustained crisis and brings together information and technology professionals, healthcare executives and clinicians, consultants, entrepreneurs, and market suppliers from around the world. Attendees can expect to explore topics such as Healthcare, Nursing, Hospital, Management, Nursing, Patient Safety, Mental Health, Telenursing, Artificial Intelligence, Medication Safety, Pharmaceuticals, and Healthcare Innovations & Quality Improvement. Looking for the documents required to avail USA Visa? Questions asked during the USA Visa Interview? Process of USA Visa? Not getting USA? Visa Appointment? Need an Invitation Letter? 15th American Healthcare, Hospital management, Nursing, And Patient Safety Summit brings together experts in the worldwide business, up-and-coming fast-growing companies, new technology inventors, and members of the investment community. It is the largest and most educational health care investment symposium in the sector. Bothered about USA Visa? We are here to assist you in applying for a visa. We will guide you through the visa process once you have registered as a speaker/listener/poster. The visa will be valid for 5-10 years. Why San Francisco? San Francisco is wellknown for the Golden Gate Bridge, its steep streets, Alcatraz, and - you guessed it, dude! - Full HouseThe thirteenth largest city in the United States is also home to several fascinating historical facts.The city is recognised for its steep rolling hills, eclectic mix of architecture throughout diverse neighbourhoods, chilly summers, fog, and sights such as the Golden Gate Bridge, cable cars, Alcatraz, and the Chinatown and Mission districts. Our Previous Conference Speakers: Dr. Barbara De Groot- Doctor of Nursing Practice Mr. Charles Hale - Founder and President of Hale Consulting Solutions LLC Mr. Sergey Sergyenko - CEO of Cybergizer Prof. Frank Chindamo - Founder & Chief Creative Officer, LaughMD Dr. Barry Lachman - President and CEO at Lachman Community Development and ConsultingServices Ms. Sue E. Goodin - CEO, ResilienceONE Prof. Robert H. Schiestl - UCLA Center of Occupational and Environmental Health Ms. Lori Beth Irvin - Founder & CEO | LBIngenuity Mr. David M. Zechman, President, The Zechman Group, and CEO of Mergestone Group Our previous and upcoming speakers and committee members: https://health.universeconferences.com/committee-members-and-speakers/ To know more visit our past report: https://health.universeconferences.com/15th-american-healthcare-hospital-management-nursing-and-patient-safety-summit/ 11th American Healthcare Summit 2022, San Francisco, USA Speakers:- Ms. Laurin Mooney from USA, DR. Claire Sorenson from USA, Ms. Leann Thieman from USA, Ms. Janelle Ali-Dinar from USA, Dr. Fernando Carvalho, Dr. Jeffrey L. Gurian, Ms. Karen D. Walker, Ms. Anhar Ali Alherz( UAE), Dr. M Health Corner, Dr. Unati Makiwane from Alberta, Mr. Jon Melton from USA To know more visit our past report: https://health.universeconferences.com/11th-american-healthcare-summit-2022-san-francisco-usa/ CALL FOR ABSTRACT IS OPEN! Primary Healthcare, Hospital Management, Mental Health and Behaviour, Metabolic Problems, Child health Poisoning, Toxicology, Environmental Health, Coronavirus disease (COVID-19), Global health ethics, Health economics, Health Equity, Health impact assessment, Adolescent health, Brain health, Health promotion, Substandard and falsified medical products, Universal Health Coverage, Urban health Vaccines and immunization. To know more about topics visit: Important Updates; Group Discount is Available (5+Members) The 15th American Healthcare, Hospital management, Nursing, And Patient Safety Summit attract over 1000+ attendees every year. Submit your Proposal to speak at an in-person conference event today Email: health@ucgconferences.com Important Information: Conference Name: 15th American Healthcare, Hospital Management, Nursing, And Patient Safety Summit Short Name: #15AHNPSUCG2025 Dates: May 14-16,2025 Venue: San Francisco, United States & Virtual Email: health@ucgconferences.com Visit: https://health.universeconferences.com/ Call for Papers: https://health.universeconferences.com/call-for-paper/ Register here: https://health.universeconferences.com/registration/ Call/WhatsApp Us: +442033222718 Target Audience; Front-Line Staff, Officers, Directors, Vice-Presidents, C-Level Executives, Physicians, Nurses, Medical Assistants, Pharmacists, Professors, Researchers, Policy Makers, Consultants, Patient Advocates, Chief Executive/Director/Associate Director/Assistant Director/Chief/Chair/Non-Clinical Director/Medical Director. Clinical Lead/Senior Clinical Health Practitioner/Head Of Clinical Service Delivery, Consultant/Senior Consultant/ /Consultant Anaesthetist, Doctor, Surgeon, Head Of Education And Training/Clinical Lead For Training And Development/Director Of Hr, Education And Training, Head Of Clinical Governance/Governance And Risk Manager/Clinical Governance And Reporting Manager, Head Of Nursing/Director Of Healthcare. AmericanNHPSUCG2025-SUPPORTING JOURNALS Unified Citation Journals is a platform for the latest discoveries in Technology, Science, engineering, medicine, medical clinical, and advancing discoveries and health. We at Unified Citation Journals ensure the advancement of healthcare and improve performance for the benefit of humanity. Unified Citation Journals empower and publish scientific research work. We will be including special issues and symposia papers in related journals from all over the world. Apart from publishing, we also promote upcoming books covering different fields of science, medicine, engineering, technology, etc. Unified Citation Journals help Authors, Publishers, and Distributors, in growing their business multifold. Social Media https://www.facebook.com/profile.php?id=100081786931096 https://www.instagram.com/healthcareucgconferences/ https://www.reddit.com/user/HMSUCG2021 https://www.tumblr.com/ https://twitter.com/HealthcareUCG https://www.linkedin.com/in/dr-rahma-taher-saleh-b3990b23b/ https://www.quora.com/profile/Dr-Rahma-Taher-Saleh https://mewe.com/i/healthcareucgconferences https://in.pinterest.com/ https://www.xing.com/profile/DrRahmaTaher_Saleh/cv https://www.youtube.com/shorts/oskSEoX2CDI More details: https://ucjournals.com/ Submit your e-posters today! Poster Community is a medium of electronic presentation of your scientific posters that allow you to present and publish the latest scientific research work of your interest in front of worldwide viewers, learners, and open access community. A poster is worth a thousand words; it’s self-explanatory – it stands on its own and does most of your explanation digitally. We welcome researchers to submit their posters and make it visible. Posters can contain many different rich resources such as research work, case reports, presentations, company profiles, assignments, images, trending news, projects, summary, results, apps, links, etc. More details: https://eposters.universeconferences.com/ ------------------------------ Community: Utilitarian Conferences Gathering Reg. No. 12330203 Registered at UCG, 12 Constance Street, London, England, E16 2DQ, UK Utilitarian Conferences Gathering, Company Reg. No. 12330203 Utilitarian Conferences Gathering offers a wide range of events, Meetings, Conferences, Workshops, symposiums. We have a dedicated team who are aimed at acquiring the technologies, adopting the knowledge of business needs, and accelerating with the best ideas and strategies. Utilitarian Conferences Gathering is a pioneer in the area of Event Management, Collaboration. We are a full-service event provider specializing in the field of Medical, Clinical, Healthcare, Life Sciences, Engineering, Pharma, Environmental Science, Engineering, Business, Agricultural, and Food event services for Academic and Industrial Sectors. We stand out distinctively from our competitors for our commitment to quality, round-the-clock service, and unmatched price. We are able to provide you with the best event, Meeting experience under one roof. We at Utilitarian Conferences Gathering make sure that you as a client choose the most appropriate event. More Information: https://universeconferences.com/ https://twitter.com/UCGConferences Facebook: https://www.facebook.com/utilitarianconferences.gathering.7 ----------------------------------- #AmericanHealthcareconference2025 #Hospitalmanagementsummit #healthcare #health #primaryhealth #nursing #patientsafety #healthcaremanagement #patientcare #occupationalhealth #healthsystem #pharmaceutical #clinicaltrials #diabetes #changemanagement #mentalhealth #familyplanning #ACP #Infectionprevention #telehealth #oralhealth #Healthcareconference (Added: Sat Mar 30 2024 Hits: 58 Rating: 0.00 Votes: 0) Rate It

• Asia Pacific DTC Laboratory Testing Market | Trends, Share, Size - The Asia-Pacific DTC Laboratory Testing Market is projected to reach $1.58 billion by 2030, at a CAGR of 12.8% from 2023 to 2030. Direct-to-consumer or DTC tests are the ones that are self-ordered by consumers without the involvement of their healthcare providers. The sample that is collected from the consumer is processed at a laboratory, and the results are then sent directly to the consumer. The growth of the Asia-Pacific DTC Laboratory testing market is driven by several factors, including the rising incidence of chronic diseases and sexually transmitted diseases, high disposable income, increased consumer awareness, increasing awareness about personal health management, benefits of DTC laboratory testing such as high convenience, affordability, and accessibility, increasing prevalence of chronic and infectious diseases, the increasing cost of healthcare, and the rising elderly population. Factors such as the growing adoption of telehealth, expansion in emerging economies, and the increasing penetration of pharmacogenomic testing in DTC laboratory testing are a few of the opportunities that would help grow the market in the future. Genetic data privacy concerns, misinterpretation of test results, and lack of professional medical counseling could be considered challenges for the Asia-Pacific DTC Laboratory testing market. However, sample integrity and interference issues, regulatory concerns, lack of reimbursement, and the limited test portfolio compared to conventional laboratory testing restrain the growth of the market. To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/asia-pacific-dtc-laboratory-testing-market-5673 The Asia-Pacific dtc laboratory testing market is segmented by Application (Genetic Testing [Ancestry/Genealogy, Disease/Risk Assessment {Cancer, Cardiovascular Diseases, Neurological Diseases, Other Diseases}, Carrier Status, Other Genetic Tests], Diabetes Testing, Routine Clinical Testing, Thyroid Function Testing, Sexually Transmitted Disease Testing, Other Applications), Sample Type (Blood, Saliva, Urine, Other Samples) and Geography. The study also evaluates industry competitors and analyzes the regional and country-level markets. Ease of Accessibility to DTC Tests and Effective Marketing to Consumers Drive Market Growth Over the last few years, consumers have been actively participating in decisions affecting their health, enabling people to be informed of their health and lead healthy lifestyles. Clinical laboratory testing is an important part of healthcare. These tests can be ordered online or bought from pharmacies without any prescription, making them easy to access for consumers. The easy accessibility and convenience of ordering the tests online also attract customers. Increasing Population Coupled with Rising Chronic Diseases The rising prevalence of chronic & infectious diseases is expected to drive the demand for DTC laboratory testing. Many DTC laboratory testing companies are offering tests for diagnosing infectious diseases and monitoring chronic diseases. China has the world’s largest population, with about 1.45 billion people as of 2023. The sheer large population of the country leads to high demand for various healthcare services, including DTC Laboratory services. The geriatric population is also estimated to reach 225 million in 2030 from 170 million in 2020. The elderly population is more prone to chronic and infectious diseases due to immune dysfunction, malnutrition, and aging-related physiological changes. The rising disease burden can directly affect a country’s social and economic status. Thus, it is necessary to adopt early diagnostic procedures to minimize the burden of these diseases. The large population, the rise in the geriatric population, and the rising prevalence of diseases have led to increased demand for DTC Laboratory testing. Thus, the advantages of DTC lab testing, such as discretion & confidentiality and the increased prevalence of sexually transmitted diseases, are expected to drive the demand for DTC lab testing. Download Sample Report Here : https://www.meticulousresearch.com/download-sample-report/cp_id=5673 The Genetic Testing Segment is Expected to Account for the Largest Share of the Market in 2023 Among all the applications, in 2023, the genetic testing segment is expected to account for the largest share of the market. DTC genetic tests are those that are provided directly to consumers without involving a healthcare provider. This testing generally offers a wide range of genetic tests that can be helpful to provide consumers with information about their ancestry, health risks, and traits. This segment is driven by factors such as increasing awareness regarding personal health management, high curiosity about self-ancestry, strong marketing strategies by the companies, rising prevalence of various genetic & chronic diseases, and high demand for personalized testing services. The Blood Segment is Expected to Account for the Largest Share of the Market in 2023 Among sample types, in 2023, the blood segment is expected to account for the largest share of the market. The blood sample is collected from consumers to test conditions such as diabetes, routine clinical testing, thyroid function, and sexually transmitted disease testing, among others, in order to gain insight into how the organs are functioning. Blood samples are collected using a lancet or a needle that is present in the kit provided to carry out the test. This segment is driven by factors such as a large variety of available tests using blood samples, increasing prevalence of various chronic diseases, and increasing consumer awareness regarding the monitoring of chronic diseases. Key Players The key players profiled in the Asia-Pacific DTC Laboratory testing market report are Metropolis Healthcare Limited (India), SRL Limited (India), Hirotsu Bio Science (Japan), Mapmygenome India Limited (India), Genesis Healthcare Co. (Japan), Augmentum Diagnostics (India), Apollo Health and Lifestyle Limited (India), WeGene (China), GeseDNATechnology LLP (China), Laboratory Corporation of America Holdings (U.S.), LetsGetChecked, Inc. (U.S.), and 23andMe Holding Co. (U.S.). The report includes a competitive landscape based on an extensive assessment of the market based on application, sample type, and geography. The report also provides insights into the geographic presence of major market players and their key growth strategies in the last three to four years. Request Sample Report: https://www.meticulousresearch.com/request-sample-report/cp_id=5673 Scope of the Report: Asia-Pacific DTC Laboratory Testing Market, by Application • Genetic Testing o Ancestry/Genealogy o Disease Risk Assessment  Cancer  Cardiovascular Diseases  Neurological Diseases  Other Diseases (Note: Disease risk assessment testing for other diseases includes celiac disease, alpha-1 antitrypsin deficiency, factor XI deficiency, glucose-6-phosphate dehydrogenase deficiency, etc.) o Carrier Status o Other Genetic Tests (Note: Other genetic tests primarily include direct-to-consumer genetic testing for pharmacogenomics, skin care DNA tests, and nutrigenomic testing.) • Diabetes Testing • Routine Clinical Testing • Thyroid Function Testing • COVID-19 Testing • Sexually Transmitted Disease Testing • Other Applications (Note: Other applications primarily include drug screening, infectious disease testing [Tuberculosis, Chicken pox, Measles, Mumps, Rubella, UTI], allergy testing, fertility, pregnancy, and nutritional testing.) Asia-Pacific DTC Laboratory Testing Market, by Sample Type • Blood • Saliva • Urine • Other Samples (Note: Other samples primarily include stool, nasopharyngeal swab, vaginal swab, buccal swab, and semen.) Asia-Pacific DTC Laboratory Testing Market, by Country • China • Japan • India • Australia • South Korea • Indonesia • Thailand • Malaysia • Singapore • Philippines • Vietnam • Rest of Asia-Pacific (RoAPAC) Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research (Added: Thu Mar 28 2024 Hits: 70 Rating: 0.00 Votes: 0) Rate It

• Drug Rehabilitation and Addiction treatment center in Lahore - Explore Lahore's best Drug Rehab & Addiction Center: Excellence in care for lifeline recovery and tailored treatments. Your path to drug-free future starts here. Call us at: 03004300300 Address: 14-FF, Abrar Business Center Wahdat Road, Lahore Visit our website: https://napakistan.org/en/ (Added: Thu Mar 28 2024 Hits: 66 Rating: 0.00 Votes: 0) Rate It

• 12th World Digital Pathology & AI UCGCongress - With this message and on behalf of the Organizing Committee, I invite you to attend and actively participate in this important international gathering. 12 World Digital Pathology & AI UCGCongress The purpose of the UCGConference is to encourage the national and international exchange of ideas between academic, corporate, industrial and government researchers. In addition to sharing knowledge, this conference provides a chance for professional networking, particularly for recent graduates, postdoctoral researchers, and individuals in the early stages of their careers. Since the previous year's conference was a great success, people from all over the world are expected to attend this year's event. The esteemed speakers come from both the world's most prestigious academic institutions and the most successful Diagnostics companies. This conference will offer the chance to discuss difficult problems in the Digital Pathology domains, including Digital Pathology, Artificial Intelligence in Digital Pathology, Machine Learning and AI, Computational Pathology, and others, as well as the practical aspects of the subject. The conference this year will take place in Duba, UAE, a city with significant historical significance UAE and the world. There will be well-known, renowned speakers from around the world who will share, debate, and analyze important new discoveries and scientific advancements that will affect clinical trials and related fields in the future. Why Dubai, UAE. The United Arab Emirates' Dubai is a city and emirate that is well-known for its upscale shopping malls, avant-garde architecture, and vibrant nightlife. The skyline dotted with skyscrapers is dominated by the 830-meter-tall Burj Khalifa tower. At its base is the Dubai Fountain, with its lights and jets that sync to music. Since the turn of the 20th century Meet Our Speaker and Organising Committee Member Dr. Zev Leifer: US President Dr. Anil Parwani: Professor and Vice Chair Pathology Dr. David J. Shulkin: Ninth Secretary, US Department of Veterans Affairs Dr. Anil Berger: VP Sales & Marketing at Mindpeak GmbH Mr. Troy Bankhead: Director of European Operations & Vice President of Marketing Dr. Michael Retsky: Hon Associate Prof at University College London Dr. Mustafa Yousif: Director of Digital Pathology at Michigan Medicine Dr. Eric Ibegbu: Medical Director and CEO at Atlantic Medical Group Ms. Ariadna Maso: Founder & CEO SANNO Dr. Lewis Hassell: University of Oklahoma Kindly find the previous editions' speakers and committee member here https://digitalpathology.ucgconferences.com/committee-members-and-speakers/ Call for Paper: Call for Abstracts is now open for the 12th World Digital Pathology & AI UCGCongress, scheduled from December 17-19, 2024 in Dubai, UAE., We invite researchers, academicians, professionals, and industry experts to contribute and share their knowledge, experiences, and research Save the dates, December 17-19, 2024. Start preparing your abstracts, and poster and don’t forget to tell your colleagues – this is going to be the best Pathologists’ conference ever! We hope that you will have a productive and fun-filled time at the 12th World Digital Pathology & AI UCGCongress Our Best Regards Conference Key Sessions: Track 1: Digital Pathology Track 2: Medical Imaging Digital Pathology Track 3: Artificial Intelligence in Digital Pathology Track 4: Computational Pathology Track 5: Pathology with Technology Track 6: Digital Pathology in COVID-19 Track 7: Machine Learning and AI Track 8: Diagnostics Digital Pathology Track 9: Digital Surgical Pathology Track 10: Digital Pathology Solutions Track 11: Pathology Informatics Track 12: Digital Histopathology For more tracks/sessions please visit here: https://digitalpathology.ucgconferences.com/submit-abstract/ Target Audience: Digital Pathologists, pathologist, Neurologist, Surgeons, Cytopathologists, Clinical and academic dermatologists, residents, fellows, mid-level Providers allied healthcare Providers students with a special interest in dermatology. Dermatopathologists, Gynecologists, Lecturers. CTOs, VPs, Directors, Senior Managers, Scientists, Doctors, Chief officers, Professors, Anatomic Pathologist, Product Managers. Conference Benefits: 21 CME Hours 21 CPD Hours Live Sessions One on one meet with Experts and Investors on Demand A showcase of new Products Certification of Recognition Industrial Exhibitions Meet your Academic idols Hear about the latest research Engage in High-level debates & Q/A Networking for future collaboration Publication of abstracts on our Website Add Research Value Employment Bureau Networking Sessions (Added: Wed Mar 27 2024 Hits: 79 Rating: 0.00 Votes: 0) Rate It

• 12th World Digital Pathology & AI UCGCongress - With this message and on behalf of the Organizing Committee, I invite you to attend and actively participate in this important international gathering. 12 World Digital Pathology & AI UCGCongress The purpose of the UCGConference is to encourage the national and international exchange of ideas between academic, corporate, industrial and government researchers. In addition to sharing knowledge, this conference provides a chance for professional networking, particularly for recent graduates, postdoctoral researchers, and individuals in the early stages of their careers. Since the previous year's conference was a great success, people from all over the world are expected to attend this year's event. The esteemed speakers come from both the world's most prestigious academic institutions and the most successful Diagnostics companies. This conference will offer the chance to discuss difficult problems in the Digital Pathology domains, including Digital Pathology, Artificial Intelligence in Digital Pathology, Machine Learning and AI, Computational Pathology, and others, as well as the practical aspects of the subject. The conference this year will take place in Duba, UAE, a city with significant historical significance UAE and the world. There will be well-known, renowned speakers from around the world who will share, debate, and analyze important new discoveries and scientific advancements that will affect clinical trials and related fields in the future. Why Dubai, UAE. The United Arab Emirates' Dubai is a city and emirate that is well-known for its upscale shopping malls, avant-garde architecture, and vibrant nightlife. The skyline dotted with skyscrapers is dominated by the 830-meter-tall Burj Khalifa tower. At its base is the Dubai Fountain, with its lights and jets that sync to music. Since the turn of the 20th century Meet Our Speaker and Organising Committee Member Dr. Zev Leifer: US President Dr. Anil Parwani: Professor and Vice Chair Pathology Dr. David J. Shulkin: Ninth Secretary, US Department of Veterans Affairs Dr. Anil Berger: VP Sales & Marketing at Mindpeak GmbH Mr. Troy Bankhead: Director of European Operations & Vice President of Marketing Dr. Michael Retsky: Hon Associate Prof at University College London Dr. Mustafa Yousif: Director of Digital Pathology at Michigan Medicine Dr. Eric Ibegbu: Medical Director and CEO at Atlantic Medical Group Ms. Ariadna Maso: Founder & CEO SANNO Dr. Lewis Hassell: University of Oklahoma Kindly find the previous editions' speakers and committee member here https://digitalpathology.ucgconferences.com/committee-members-and-speakers/ Call for Paper: Call for Abstracts is now open for the 12th World Digital Pathology & AI UCGCongress, scheduled from December 17-19, 2024 in Dubai, UAE., We invite researchers, academicians, professionals, and industry experts to contribute and share their knowledge, experiences, and research Save the dates, December 17-19, 2024. Start preparing your abstracts, and poster and don’t forget to tell your colleagues – this is going to be the best Pathologists’ conference ever! We hope that you will have a productive and fun-filled time at the 12th World Digital Pathology & AI UCGCongress Our Best Regards Conference Key Sessions: Track 1: Digital Pathology Track 2: Medical Imaging Digital Pathology Track 3: Artificial Intelligence in Digital Pathology Track 4: Computational Pathology Track 5: Pathology with Technology Track 6: Digital Pathology in COVID-19 Track 7: Machine Learning and AI Track 8: Diagnostics Digital Pathology Track 9: Digital Surgical Pathology Track 10: Digital Pathology Solutions Track 11: Pathology Informatics Track 12: Digital Histopathology For more tracks/sessions please visit here: https://digitalpathology.ucgconferences.com/submit-abstract/ Target Audience: Digital Pathologists, pathologist, Neurologist, Surgeons, Cytopathologists, Clinical and academic dermatologists, residents, fellows, mid-level Providers allied healthcare Providers students with a special interest in dermatology. Dermatopathologists, Gynecologists, Lecturers. CTOs, VPs, Directors, Senior Managers, Scientists, Doctors, Chief officers, Professors, Anatomic Pathologist, Product Managers. Conference Benefits: 21 CME Hours 21 CPD Hours Live Sessions One on one meet with Experts and Investors on Demand A showcase of new Products Certification of Recognition Industrial Exhibitions Meet your Academic idols Hear about the latest research Engage in High-level debates & Q/A Networking for future collaboration Publication of abstracts on our Website Add Research Value Employment Bureau Networking Sessions (Added: Wed Mar 27 2024 Hits: 70 Rating: 0.00 Votes: 0) Rate It

• Global Conference on Pediatrics and Neonatology - Global Conference on Pediatrics and Neonatology (GCPN 2024) is focused on providing the latest advances in pediatric research, Neonatology and evidence-based practice to improve the quality of children’s health care. This annual learning event emphasizes practical application of current concepts that pediatricians, pediatric specialists, family physicians and advanced practice providers involved in the care of children and adolescents can apply in their practice. Visit: https://pediatrics.lambdaconferences.com/ Our goal is to bring together many of our investigators from our Department to present their progress made in various areas of research. Speakers represent many disciplines using a broad-spectrum of translational research and methodologies in each area. The scientific program can be viewed as a series of parallel speciality conferences that cover the latest hot topics and developments across specialities of pediatrics. Main theme of the conference is "Innovations in Pediatric Healthcare: Shaping Bright Futures". Join us in London for a unique education experience in one of the most fascinating cities in the world. (Added: Tue Mar 26 2024 Hits: 68 Rating: 0.00 Votes: 0) Rate It

• Ventilators Market Size Report, 2024 - 2031 - Meticulous Research®—a leading market research company, published a research report titled, ‘Ventilators Market by Product (Instrument, Catheter, Mask, Tube) Mobility (Intensive Care, Portable) Interface (Invasive, Non-invasive) Age Group (Adult, Neonatal) Mode (Volume, Pressure, Dual) End User (Hospital, ASC, Home Care) – Global Forecast to 2031’ According to this latest publication from Meticulous Research®, the Ventilators market is projected to reach $13.23 billion by 2031, at a CAGR of 8.3% from 2024 to 2031. The growth of the ventilators market is driven by factors such as the increasing number of intensive care units (ICUs) and ICU beds, the rising incidence & prevalence of respiratory diseases, rapid urbanization coupled with rising pollution levels, the growth in the geriatric population, and the rising incidence of preterm births. However, the high costs of ventilators and the high preference for alternative oxygenation therapies restrain the market’s growth. The increasing demand for homecare therapeutic devices and emerging economies in Asia-Pacific and Latin America are expected to create market growth opportunities. However, the adverse effects of ventilators on neonates and difficulties in maintaining component supply chains pose challenges to the market’s growth. To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/ventilators-market-5093 The ventilators market is segmented by Product (Ventilator Accessories [Ventilator Catheters, Endotracheal Tubes, Ventilator Masks, and Other Ventilator Accessories], Ventilator/Instrument), Mobility (Intensive Care Ventilators and Portable Ventilators), Interface (Invasive Ventilators and Non-invasive Ventilators), Age Group (Adult & Pediatric and Neonatal & Infant), Mode (Volume Mode Ventilation, Dual/Combined Mode Ventilation, Pressure Mode Ventilation, and Other Ventilation Modes), End User (Hospitals, Homecare Settings, Ambulatory Surgical Centers (ASCs) and Other End Users) and Geography. The study also evaluates industry competitors and analyzes the regional and country-level markets. Among the products studied in this report, in 2024, the ventilator accessories segment is expected to account for the largest share of the market. The large market share of this segment can be attributed to the extensive utilization of ventilator accessories, the rising awareness regarding hospital hygiene practices, and the additional functionality of certain accessories in medication administration. Download Sample Report Here : https://www.meticulousresearch.com/download-sample-report/cp_id=5093 Based on mobility, in 2024, the intensive care ventilators segment is expected to account for the largest share of the market. The large market share of this segment can be attributed to the increasing installation of ventilators in ICUs, the availability of reimbursements for ventilation solutions and respiratory treatment procedures, the growing number of patient admissions in CCUs due to the increasing population afflicted with chronic and respiratory infectious diseases, and the rising incidence of preterm births worldwide. Among the interfaces studied in this report, in 2024, the invasive ventilators segment is expected to account for the largest share of the market. The large market share of this segment can be attributed to the widespread utilization of invasive ventilators in ICUs for patients with chronic respiratory and infectious diseases, neurological disorders, and sleep disorders. Among the age groups studied in this report, the adult & pediatric segment is expected to account for the largest share of the market. The large market share of this segment can be attributed to the high adoption of ventilation support among the elderly population, their increased vulnerability to chronic and infectious diseases, and the rising consumption of tobacco-related products. Request for Sample: https://www.meticulousresearch.com/request-sample-report/cp_id=5093 Among the modes studied in this report, in 2024, the volume mode ventilation segment is expected to account for the largest share of the market. The large market share of this segment can be attributed to the widespread adoption of volume-controlled ventilators in intensive care units due to their advantages, including precise minute ventilation and consistent tidal volume delivery. Among the end users studied in this report, in 2024, the hospitals segment is expected to account for the largest share of the market. The large market share of this segment can be attributed to the considerable number of patients afflicted with respiratory illnesses, the presence of skilled medical practitioners in hospitals, and the accessibility to advanced healthcare facilities equipped with state-of-the-art medical devices such as ventilators. Among the geographies studied in this report, in 2024, North America is expected to account for the largest share of the market. North America’s significant market share can be attributed to its well-established healthcare infrastructure, widespread adoption of advanced technologies, the presence of major market players, high demand for technologically advanced medical equipment, a growing elderly population, and rising demand for long-term and home healthcare solutions. Key Players The key players profiled in the ventilators market report are Schiller AG (Switzerland), Hamilton Medical AG (Switzerland), Koninklijke Philips N.V. (Netherlands), GE HealthCare Technologies, Inc. (U.S.), Medtronic plc (Ireland), Getinge AB (Sweden), ResMed Inc. (U.S.), Zoll Medical Corporation (U.S.), Drägerwerk AG & Co. KGaA (Germany), Fisher & Paykel Healthcare Limited (New Zealand), and VYAIRE MEDICAL, INC. (U.S.). Customize my Report: https://www.meticulousresearch.com/request-customization/cp_id=5093 Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research (Added: Tue Mar 26 2024 Hits: 66 Rating: 0.00 Votes: 0) Rate It

• Vendor Neutral Archive (VNA) & PACS Market Size In 2024 - The VNA & PACS Market is projected to reach $6.50 billion by 2031, at a CAGR of 7.2% from 2024 to 2031. Vendor Neutral Archive (VNA) & Picture Archiving and Communication System (PACS) are medical image management solutions used for aiding diagnosis, comparing images between patients or within the same patient at different time points to assess the progress of the disease, and evaluating prognosis. These solutions are used to replace physical archiving by storing all medical image datasets digitally in an organized manner. Such solutions also allow the integration of medical image data with patient data in other records, such as electronic health records, health information systems, and radiology information systems (RIS). To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/vna-and-pacs-market-4440 Medical imaging uses various imaging modalities, such as X-ray, Computed Tomography (CT), and Magnetic Resonance Imaging (MRI), to diagnose diseases. It also helps view and analyze the body’s internal conditions. Factors driving investments in medical imaging technologies include efforts by government bodies to modernize imaging facilities and research, the proliferation of diagnostic imaging centers, technological advancements in diagnostic imaging modalities, and patients’ increasing preference for minimally invasive treatments. EMR and PACS can view images using the EMR enterprise PACS/VNA integration. Therefore, companies have developed integrated platforms. For instance, the INFINITT Healthcare Platform (IHP) of INFINITT North America Inc. (U.S.) offers full integration with EMRs for content sharing and display. The platform fully supports various data formats beyond DICOM, managing DICOM and non-DICOM data on an Oracle database. Similarly, Change Healthcare’s (U.S.) Conserus Image Repository integrates with all major PACS, cardiac PACS, and EMR vendors through a standard EMR web API. Download free Sample Report: https://www.meticulousresearch.com/download-sample-report/cp_id=4440 The Departmental PACS Segment is Expected to Account for the Larger Share of the Market in 2024 Among the procurement models of PACS covered in this report, in 2024, the departmental PACS segment is expected to account for the larger share of the PACS market. The large market share of this segment can be attributed to the increasing adoption of these PACS to process large volumes of images. Radiology departments use these PACS due to their ability to solve radiology-related issues by digitalizing the traditional process, improving efficiency, ensuring data privacy & security, and enhancing image access. Most PACS have image viewing & annotation tools built into them to obtain proper conclusions and plan treatment, contributing to their widespread adoption. The Enterprise VNA Segment is Expected to Account for the Larger Share of the Market in 2024 Among the procurement models of VNA covered in this report, in 2024, the enterprise VNA segment is expected to account for the larger share of the VNA market. The large market share of this segment can be attributed to the increasing need to aggregate data across multiple sites to improve care coordination across sites of care. Request Sample: https://www.meticulousresearch.com/request-sample-report/cp_id=4440 The On-Premise VNA Segment is Expected to Account for the Largest Share of the Market in 2024 Among the delivery models covered in this report, in 2024, the on-premise VNA segment is expected to account for the largest share of the VNA market. The benefit of the on-premise VNA delivery model, specifically for organizations that are migrating or upgrading from one system to another, is the ability to reuse existing servers and storage hardware. Hardware reuse alleviates costs, particularly for smaller organizations that distribute the cost of server hardware over a relatively small number of users. The Computed Tomography (CT) Segment is Expected to Account for the Largest Share of the Market in 2024 Among the imaging modalities covered in this report, in 2024, the Computed Tomography (CT) segment is expected to account for the largest share of the VNA & PACS market. The large market share of this segment can be attributed to the rising demand for imaging services and technological advancement in CT having drastically boosted image resolution, quality, and diagnostic capabilities. These improvements have turned CT scanning into a vital tool in medical imaging, resulting in higher demand for storage and administration solutions such as VNA and PACS. Customization Report: https://www.meticulousresearch.com/request-customization/cp_id=4440 The Hospitals Segment is Expected to Account for the Largest Share of the Market in 2024 Among the end users covered in this report, in 2024, the hospitals segment is expected to account for the largest share of the VNA & PACS market. This segment’s large market share can be attributed to the higher patient visits and admissions, efficient management of patient data, and initiatives undertaken to implement advanced technologies. Asia-Pacific: Fastest-growing Regional Market The market in Asia-Pacific is projected to register the highest growth rate during the forecast period. The growth of this regional market can be attributed to the rising investment in the healthcare sector for improving healthcare infrastructure and digital health, the adoption of advanced imaging modalities into the healthcare industry, and the presence of major VNA & PACS software developers in countries such as China, India, Singapore, and Japan, and technological advancements related to diagnostic imaging, and, government initiatives aiming to increase the utilization of EMR and telehealth services. Buy Now: https://www.meticulousresearch.com/Checkout/35265421 Key Players The report offers a competitive landscape based on an extensive assessment of the software offerings and geographic presence of leading market players and the key growth strategies adopted by them over the past three to four years. The key players profiled in the VNA & PACS market report are Novarad Corporation (U.S.), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers AG (Germany), Agfa-Gevaert NV (Belgium), Mach7 Technologies (Australia), GE HealthCare Technologies Inc. (U.S.), Fujifilm Holdings Corporation (Japan), Sectra AB (Sweden), Bridgehead Software, Ltd. (U.K.), INFINITT Healthcare Co., Ltd. (South Korea), Hyland Software, Inc. (U.S.), ASPYRA, LLC (U.S.), Merative L.P. (U.S.), SoftTeam Solutions Pvt Ltd. (India), Carestream Health, Inc. (U.S.), and Neusoft Corporation (China). Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research (Added: Tue Mar 26 2024 Hits: 82 Rating: 0.00 Votes: 0) Rate It

• Active 360 Revolutionizes Team Building and Personal Training in London - London, UK - In a significant move for fitness enthusiasts and corporations alike, Active 360 has unveiled its innovative approach to personal training and team building activities in London. This dual offering combines a state-of-the-art personal training facility in Chiswick with unique, environmentally focused team building experiences on London's picturesque waterways.
  
  Premier Personal Training Facilities in Chiswick
  
  Situated near the iconic Kew Bridge, Active 360's gym in Chiswick is more than just a fitness space; it's a hub of creativity and achievement where personal trainers can bring their client's fitness dreams to life. The gym is equipped with the latest in fitness technology, offering a broad spectrum of workout possibilities, from high-intensity interval training to serene yoga sessions.
  
  Comprehensive Fitness Solutions
  
  Active 360 caters to a wide array of fitness regimes with its extensive selection of equipment and amenities. The gym's flexible rental options empower personal trainers to craft bespoke, impactful workout sessions for their clients, ensuring each individual's fitness goals are met with precision and care.
  
  Fostering a Fitness Community
  
  The heart of Active 360's gym lies in its vibrant community. Trainers and clients alike thrive in this supportive environment, where every workout is an opportunity to push boundaries and celebrate achievements. This sense of camaraderie is pivotal to the gym's philosophy, fostering a space where fitness journeys are shared, and goals are reached collectively.
  
  Innovative Team Building with Paddle and Pick
  
  Active 360's "Paddle and Pick" initiative introduces a revolutionary team building concept, merging the thrill of paddleboarding with a commitment to environmental stewardship. Participants are not only treated to a comprehensive paddleboarding experience but are also given the chance to contribute to the cleanup of London's waterways, enhancing their environmental awareness and team spirit.
  
  Environmental Engagement and Corporate Responsibility
  
  In line with their mission to combat plastic pollution, Active 360 offers businesses a unique opportunity to engage in meaningful team building that aligns with corporate social responsibility goals. The "Paddle and Pick" sessions are a testament to Active 360's dedication to creating a sustainable future, inviting corporate teams to partake in this vital environmental initiative.
  
  Versatile Team Building Locations
  
  Active 360 boasts several centrally located sites across London, including the scenic Brentford and the bustling Paddington Basin, providing easy access for corporate groups seeking an unforgettable team building experience. Each location offers a unique backdrop for Active 360's environmentally conscious paddleboarding adventures.
  
  Booking Your Next Adventure
  
  For those eager to experience Active 360's exceptional personal training facilities or partake in their groundbreaking team building activities, information on booking and upcoming events can be found on their website. Early booking is recommended to secure your preferred date and time for an unforgettable fitness experience.
  
  Conclusion
  
  Active 360 stands at the forefront of integrating fitness and environmental activism, offering unparalleled personal training and team building experiences in London. Join them on their mission to foster health, teamwork, and sustainability in one of the world's most vibrant cities.
  
  Contact Information
  
  For inquiries and bookings, contact Active 360 at 0203 393 5360 or visit their website. Embark on your fitness journey at their Gyms Chiswick or plan your next Team Building Ideas London event with Active 360, where fitness meets environmental consciousness. (Added: Mon Mar 25 2024 Hits: 53 Rating: 0.00 Votes: 0) Rate It

• Leicester-Based Company Revolutionizes Emergency Medical Care with Advanced Medical Batteries - Leicester, UK - Euro Energy, a leading supplier of Medical Batteries in the UK, is proud to announce the latest advancements in medical battery technology, enhancing the reliability and efficiency of life-saving medical devices. The company's commitment to innovation is exemplified through its comprehensive range of original manufacturer medical batteries, including the Zoll Autopulse 8700-0752-01 Original Medical Battery, Philips IntelliVue MX40 989803174131 Original Medical Battery 3-pack, and the Physio Control Lucas 3 Chest Compression System Original Medical Battery (Dark Grey) 11576-000080.
  
  Euro Energy's CEO stated, "Our dedication to supporting the healthcare industry with high-quality and reliable power solutions is unwavering. These advanced medical batteries represent a significant leap forward in ensuring that medical devices, such as defibrillators, patient monitors, and chest compression systems, operate at their peak efficiency when lives are at stake."
  
  Innovative Medical Battery Solutions
  
  • Zoll Autopulse 8700-0752-01 Original Medical Battery: This lithium-ion battery is specifically designed for the Zoll AutoPulse® Resuscitation System, providing high-quality automated CPR to victims of sudden cardiac arrest. Its reliability and longevity ensure uninterrupted life-saving care during critical moments.
  
  • Philips IntelliVue MX40 989803174131 Original Medical Battery 3-Pack: Tailored for the Philips IntelliVue MX40 patient wearable monitor, this 3-pack of lithium rechargeable batteries enables continuous monitoring of patients, offering mobility without compromising care quality.
  
  • Physio Control Lucas 3 Chest Compression System Original Medical Battery: A rechargeable lithium-polymer battery designed for the LUCAS 3 Chest Compression System, ensuring effective, consistent, and continuous chest compressions with a battery life that supports prolonged operations.
  
  These batteries not only enhance the operational capabilities of medical devices but also embody Euro Energy's commitment to quality, safety, and innovation. Registered with the MHRA and conforming to the Medical Devices Directive 93/42/EEC, Euro Energy ensures that all products meet the highest standards required by healthcare professionals.
  
  About Euro Energy
  
  Euro Energy is the number one medical battery supplier to the NHS and a leader in the medical battery industry, known for its exceptional product quality and customer service. With nearly 40 years of experience, Euro Energy supplies the most comprehensive range of original manufacturer medical batteries in the UK.
  
  For further details on this product, you might find it helpful to explore more on the Euro Energy website, which offers a wide range of original manufacturer medical batteries from leading healthcare companies​ or call 0116 2340567.
  
  Contact:
  
  Euro Energy Resources Limited
  
  10 Barrington Business Park, Leycroft Road,
  
  Leicester, LE4 1ET, UK
  
  0116 2340567
  
  Info@euroenergy.co.uk (Added: Mon Mar 25 2024 Hits: 58 Rating: 0.00 Votes: 0) Rate It

• Thyroid Test Prices at Lupin Diagnostics - Maintaining a healthy thyroid is crucial for overall well-being, influencing various bodily functions. Regular thyroid testing is essential to detect imbalances early on. If you're con-cerned about thyroid test prices, Lupin Diagnostics offers a transparent and quality-driven approach to ensure affordability without compromising on accuracy. The Significance of Thyroid Testing: The thyroid gland plays a central role in regulating metabolism, energy production, and var-ious bodily functions. Imbalances in thyroid hormone levels can lead to a range of health issues. Timely thyroid testing is crucial for early detection and effective management of thyroid-related concerns. Affordability without Compromise: At Lupin Diagnostics, we understand that concerns about healthcare costs should never hin-der your commitment to thyroid health. Our commitment to affordability is reflected in our transparent approach to thyroid test prices. We believe that everyone should have access to accurate thyroid testing without financial barriers, ensuring that you can prioritize your health with confidence. Transparent Pricing: Lupin Diagnostics takes pride in transparency when it comes to pricing. We believe that un-derstanding the financial aspect of healthcare empowers individuals to make informed deci-sions. Our thyroid test prices are clearly communicated, with no hidden fees or surprises. Your journey to thyroid wellness starts with clarity and confidence. Customized Packages: To further enhance affordability and cater to individual needs, Lupin Diagnostics provides customized health check-up packages that often include thyroid tests. These packages allow you to address specific health concerns while optimizing costs. Lupin Diagnostics is committed to tailoring solutions that prioritize your health and budget. Quality Assurance: While Lupin Diagnostics prioritizes affordability, we never compromise on the quality of our services. Our experienced team adheres to stringent quality control measures, ensuring accurate and reliable thyroid test results. Your health is our priority, and Lupin Diagnostics is dedicated to delivering excellence in thyroid diagnostics. Convenience in Accessibility: With Lupin Diagnostics operating in 80+ cities, accessing quality thyroid health diagnostics has never been more convenient. Our 36+ labs and 600+ collection centers are strategically located, ensuring that you can find a Lupin Diagnostics facility near you. Prioritize your thyroid health without compromising on accessibility. In conclusion, prioritizing your thyroid health should be a straightforward and affordable journey. By choosing Lupin Diagnostics, you not only gain access to accurate thyroid tests but also contribute to a holistic approach to your well-being. Visit Our Website @ https://www.lupindiagnostics.com/ (Added: Fri Mar 22 2024 Hits: 74 Rating: 0.00 Votes: 0) Rate It

• Thyroid Test Prices at Lupin Diagnostics - Maintaining a healthy thyroid is crucial for overall well-being, influencing various bodily functions. Regular thyroid testing is essential to detect imbalances early on. If you're con-cerned about thyroid test prices, Lupin Diagnostics offers a transparent and quality-driven approach to ensure affordability without compromising on accuracy. The Significance of Thyroid Testing: The thyroid gland plays a central role in regulating metabolism, energy production, and var-ious bodily functions. Imbalances in thyroid hormone levels can lead to a range of health issues. Timely thyroid testing is crucial for early detection and effective management of thyroid-related concerns. Affordability without Compromise: At Lupin Diagnostics, we understand that concerns about healthcare costs should never hin-der your commitment to thyroid health. Our commitment to affordability is reflected in our transparent approach to thyroid test prices. We believe that everyone should have access to accurate thyroid testing without financial barriers, ensuring that you can prioritize your health with confidence. Transparent Pricing: Lupin Diagnostics takes pride in transparency when it comes to pricing. We believe that un-derstanding the financial aspect of healthcare empowers individuals to make informed deci-sions. Our thyroid test prices are clearly communicated, with no hidden fees or surprises. Your journey to thyroid wellness starts with clarity and confidence. Customized Packages: To further enhance affordability and cater to individual needs, Lupin Diagnostics provides customized health check-up packages that often include thyroid tests. These packages allow you to address specific health concerns while optimizing costs. Lupin Diagnostics is committed to tailoring solutions that prioritize your health and budget. Quality Assurance: While Lupin Diagnostics prioritizes affordability, we never compromise on the quality of our services. Our experienced team adheres to stringent quality control measures, ensuring accurate and reliable thyroid test results. Your health is our priority, and Lupin Diagnostics is dedicated to delivering excellence in thyroid diagnostics. Convenience in Accessibility: With Lupin Diagnostics operating in 80+ cities, accessing quality thyroid health diagnostics has never been more convenient. Our 36+ labs and 600+ collection centers are strategically located, ensuring that you can find a Lupin Diagnostics facility near you. Prioritize your thyroid health without compromising on accessibility. In conclusion, prioritizing your thyroid health should be a straightforward and affordable journey. By choosing Lupin Diagnostics, you not only gain access to accurate thyroid tests but also contribute to a holistic approach to your well-being. Visit Our Website @ https://www.lupindiagnostics.com/ (Added: Fri Mar 22 2024 Hits: 76 Rating: 0.00 Votes: 0) Rate It

• Thyroid Test Prices at Lupin Diagnostics - Maintaining a healthy thyroid is crucial for overall well-being, influencing various bodily functions. Regular thyroid testing is essential to detect imbalances early on. If you're con-cerned about thyroid test prices, Lupin Diagnostics offers a transparent and quality-driven approach to ensure affordability without compromising on accuracy. The Significance of Thyroid Testing: The thyroid gland plays a central role in regulating metabolism, energy production, and var-ious bodily functions. Imbalances in thyroid hormone levels can lead to a range of health issues. Timely thyroid testing is crucial for early detection and effective management of thyroid-related concerns. Affordability without Compromise: At Lupin Diagnostics, we understand that concerns about healthcare costs should never hin-der your commitment to thyroid health. Our commitment to affordability is reflected in our transparent approach to thyroid test prices. We believe that everyone should have access to accurate thyroid testing without financial barriers, ensuring that you can prioritize your health with confidence. Transparent Pricing: Lupin Diagnostics takes pride in transparency when it comes to pricing. We believe that un-derstanding the financial aspect of healthcare empowers individuals to make informed deci-sions. Our thyroid test prices are clearly communicated, with no hidden fees or surprises. Your journey to thyroid wellness starts with clarity and confidence. Customized Packages: To further enhance affordability and cater to individual needs, Lupin Diagnostics provides customized health check-up packages that often include thyroid tests. These packages allow you to address specific health concerns while optimizing costs. Lupin Diagnostics is committed to tailoring solutions that prioritize your health and budget. Quality Assurance: While Lupin Diagnostics prioritizes affordability, we never compromise on the quality of our services. Our experienced team adheres to stringent quality control measures, ensuring accurate and reliable thyroid test results. Your health is our priority, and Lupin Diagnostics is dedicated to delivering excellence in thyroid diagnostics. Convenience in Accessibility: With Lupin Diagnostics operating in 80+ cities, accessing quality thyroid health diagnostics has never been more convenient. Our 36+ labs and 600+ collection centers are strategically located, ensuring that you can find a Lupin Diagnostics facility near you. Prioritize your thyroid health without compromising on accessibility. In conclusion, prioritizing your thyroid health should be a straightforward and affordable journey. By choosing Lupin Diagnostics, you not only gain access to accurate thyroid tests but also contribute to a holistic approach to your well-being. Visit Our Website @ https://www.lupindiagnostics.com/ (Added: Fri Mar 22 2024 Hits: 84 Rating: 0.00 Votes: 0) Rate It

• Pioneering Spinal Care: The Future of Neurosurgery at Spinal Surgery Clinic in Basingstoke - Basingstoke, UK- In an era where spinal health issues increasingly impede daily life for many, the Spinal Surgery Clinic in Basingstoke emerges as a lighthouse of hope and innovation. Under the stewardship of Mr Ali Nader-Sepahi, a luminary in the field of spinal neurosurgery, the clinic heralds a new chapter in compassionate, cutting-edge care for individuals suffering from spinal ailments.
  
  Cutting-Edge Spinal Surgeon Southampton Solutions
  
  The Spinal Surgery Clinic distinguishes itself through a profound commitment to advancing spinal care, offering a comprehensive suite of treatments for conditions ranging from common back pain and sciatica to complex spinal tumors and nerve-related conditions. Embracing the latest in microsurgical technology, the clinic ensures that each procedure is marked by precision, minimizing discomfort and hastening recovery.
  
  Expertise You Can Trust
  
  At the helm of the clinic's visionary approach is Mr Ali Nader-Sepahi, whose credentials and compassionate care are unparalleled. With a rich tapestry of expertise woven through years of dedicated practice, Mr Nader-Sepahi's work is a testament to the clinic's ethos of excellence and patient-centered care. His affiliations with prestigious institutions, alongside a private practice that spans Basingstoke and Southampton, underscore his commitment to accessible, top-tier spinal care.
  
  Comprehensive Patient Care
  
  Recognizing that the journey to recovery is as significant as the treatment itself, the Spinal Surgery Clinic prides itself on a patient-first philosophy. From the warmth of the initial welcome by our dedicated staff to the tailored post-operative care plans, every step is designed to ensure comfort, clarity, and confidence for our patients and their families.
  
  A Call to Action for Spinal Health
  
  Living with spinal issues can be a daunting prospect, but it doesn't have to be a lifelong sentence. The clinic stands ready to assist those plagued by persistent pain or symptoms suggestive of more serious conditions, advocating for early intervention as a key to better outcomes.
  
  Our Pledge to Excellence
  
  The Spinal Surgery Clinic's reputation is built on a foundation of trust, innovation, and success, reflected in the heartfelt testimonials of our patients. Our collaboration with leading insurance providers and our open-door policy for self-referrals exemplify our belief that exceptional spinal care should be within everyone's reach.
  
  As we look to the future, the Spinal Surgery Clinic remains dedicated to embodying the pinnacle of spinal health advancements, continually evolving to meet the needs of our patients with empathy, expertise, and excellence. We invite you to join us on this journey to reclaim your health and vitality.
  
  Embark on Your Journey to Recovery
  
  Don't let spinal issues dictate the course of your life. Reach out to the Spinal Surgery Clinic for a consultation with Mr Ali Nader-Sepahi and take the first step towards a brighter, pain-free future.
  
  For more information or to schedule your appointment, please contact us at 01256 315 025 or visit our welcoming facility in Basingstoke. (Added: Thu Mar 21 2024 Hits: 59 Rating: 0.00 Votes: 0) Rate It

• Safe Evacuation by Aeromed Air Ambulance Service in Kolkata - Kolkata, March 20, 2023 - Aeromed Air Ambulance Service, a leading provider of air medical transportation, has successfully demonstrated its commitment to patient care by ensuring safe evacuations during critical moments. With its advanced medical facilities and highly trained professionals, Aeromed Air Ambulance Service in Kolkata has emerged as a trusted name in the field of emergency medical transportation. The Convenient Journey Has Been Provided by The Aeromed Air Ambulance Service in Kolkata for Severe Patient with All Medical Lavishness During a critical moment, every second counts. It is crucial to have a reliable medical evacuation service that can swiftly transport patients to the required medical facility. Aeromed Air Ambulance Service in Kolkata understands this urgency and has tailored its services to meet the unique needs of each patient. Equipped with state-of-the-art aircraft and cutting-edge medical equipment, Aeromed Air Ambulance Service ensures that patients receive the highest level of care during their journey. Highly skilled medical professionals, including doctors, nurses, and paramedics, are on board to provide immediate and specialized medical attention throughout the evacuation process. "At Aeromed Air Ambulance Service, patient safety and well-being are our top priorities," said one of the expert medical paramedic staff of Aeromed Air Ambulance. "We understand the criticality of the situations we encounter, and our dedicated team works tirelessly to ensure the safe and efficient evacuation of patients." The approach to patient care onboard is comprehensive and includes continuous monitoring of vital signs, administering necessary medication, and providing life-saving interventions when required. This approach, combined with the expertise of the medical team, guarantees that patients are in safe hands throughout their journey. Aeromed Air Ambulance Service is known for its quick response time, ensuring that patients receive immediate medical attention and are transferred to the appropriate medical facility without any delay. The service operates round the clock, providing 24/7 emergency medical transportation in Kolkata and its surrounding areas. In addition to its commitment to patient care, Aeromed Air Ambulance Service in Kolkata also places great importance on maintaining the highest standards of safety. The company adheres to rigorous protocols and undergoes regular inspections and audits to ensure compliance with industry regulations. For individuals in need of reliable and safe medical evacuation services in Kolkata, Aeromed Air Ambulance Service is the trusted choice. Their exceptional approach to patient care and their focus on safety has made them a preferred provider in the region. Aeromed Air Ambulance Service in Guwahati Has Also Launches Reliable and Rapid Medical Evacuation Aeromed Air Ambulance Service in Guwahati has recently launched its reliable and rapid medical evacuation services, further expanding its commitment to providing swift and efficient healthcare transportation. With a strong focus on patient care and safety, Aeromed Air Ambulance Service ensures that critical patients in Guwahati and surrounding areas can receive timely medical assistance during emergencies. Equipped with advanced medical equipment and staffed by highly trained professionals, Aeromed Air Ambulance Service stands as a trusted provider for those in need of urgent medical evacuation services in Guwahati. (Added: Wed Mar 20 2024 Hits: 72 Rating: 0.00 Votes: 0) Rate It

• CAR T-cell Therapy Market Insights, 2023-2030 - According to this latest publication from Meticulous Research®, the CAR T-cell therapy market is projected to reach $51.6 billion by 2030, at a CAGR of 43.3% from 2023 to 2030. The growth of this market is driven by increasing cancer prevalence, a rise in awareness regarding CAR T-cell therapy, and increasing R&D activities and clinical trials. However, the complex manufacturing process and adverse effects of the therapy may restrain the growth of this market. Additionally, a high scope in emerging economies, innovation in CAR T-cell therapies and manufacturing processes are creating opportunities for market growth. Moreover, the high treatment cost of therapy and the lack of skilled professionals are challenging factors for the market. To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/car-t-cell-therapy-market-5508 Developments in Cell Therapies to Offer Significant Opportunities for the CAR T-cell Therapy Market Growth Consistent developments in CAR T-cell therapy at various stages will positively impact its efficacy. Some of these developments include allogeneic CAR T-cell procedures. This procedure avoids the issues with autologous CAR T-cells in harvesting, product variability, long vein-to-vein time, and T-cell dysfunction. This treatment will help to expand the patient category, such as those with low T-cell levels, harvest failures, or who need treatment before autologous CAR T-cells can be manufactured. Another major development is in the viral-vector capacity. The viral-vector capacity constraint and a limited number of third-party suppliers lead to the in-house production of these viral vectors. Also, the lenti or adeno-associated-virus-based approaches are time-consuming and inefficient. Hence, the need for efficient gene-transfer tools enables rapid modification of T-cells with CARs and additional modifications such as removing donor T-cell receptors, adding on-off switches that can turn off the CAR T to prevent toxicity, and secreted factors. These advanced gene-transfer tools may allow the testing of multiple modifications leading to more effective therapy processes. Moreover, high-quality assays, process innovations including cloud-based data transfer, and tracking and validating each step of manufacturing contribute to the increased demand for CAR T-Cell therapy in coming years. Download Sample Report Here : https://www.meticulousresearch.com/download-sample-report/cp_id=5508 The CAR T-cell therapy market is segmented by drug type {Abecma [idecabtagene vicleucel], Breyanzi [lisocabtagene maraleucel], Kymriah [tisagenlecleucel], Tecartus [brexucabtagene autoleucel], Yescarta [axicabtagene ciloleucel], and Carvykti [ciltacabtagene autoleucel]}, Target Antigen (CD, BCMA, HER2, Other Target Antigens), indication (lymphoma, acute lymphoblastic leukemia, non-Hodgkin’s lymphoma, multiple myeloma, acute myeloid leukemia, other indications), and geography. The study also evaluates industry competitors and analyzes the regional and country-level markets. Based on drug type, in 2023, the Yescarta (axicabtagene ciloleucel) segment is expected to account for the largest share of the CAR T-cell therapy market. The axicabtagene ciloleucel is used to treat B-cell lymphoma in adults. It helps overcome the body's immune system's weaknesses in cancer elimination, such as potentially poor T-cell function and inadequate amounts of tumor-specific T-cells, contributing to the large market share of this segment. Request for Sample: https://www.meticulousresearch.com/request-sample-report/cp_id=5508 Based on target antigen, in 2023, the CD target antigen segment is expected to account for the largest share of the CAR T-cell therapy market. CD antigens are commonly found as surface antigens in various cancer cases. Hence, the therapy developed was particularly against CD antigens, contributing to the large market share of this segment. Based on indication, in 2023, the lymphoma segment is expected to account for the largest share of the CAR T-Cell therapy market. The large market share of this segment is attributed to the increased number of lymphoma patients adopting CAR T-cell therapy as their treatment over others due to its effectiveness and positive results. Geographic Review This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, and the Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), Latin America, and the Middle East & Africa. In 2023, North America is expected to account for the largest share of the CAR T-cell therapy market, followed by Europe and Asia-Pacific. Advanced healthcare infrastructure in the U.S. and Canada, the high adoption of advanced technologies, highly skilled professionals available for performing cancer treatment research studies and clinical studies, and the growing number of approvals boost the growth of this market in North America. Customize my Report: https://www.meticulousresearch.com/request-customization/cp_id=5508 Key Players The key players operating in the CAR T-cell therapy market are Novartis AG (Switzerland), bluebird bio, Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Caribou Biosciences, Inc. (U.S.), Cartesian Therapeutics, Inc. (U.S.), Pfizer Inc. (U.S.), Cellectis S.A. (France), Celyad Oncology SA (Belgium), Gilead Sciences, Inc. (U.S.), Intellia Therapeutics, Inc. (U.S.), Merck & Co., Inc. (U.S.), Amgen Inc. (U.S.), Inovio Pharmaceuticals, Inc. (U.S.), and OncoTherapy Science, Inc. (Japan). Scope of the Report: CAR T-cell Therapy Market Size & Trend Analysis, by Drug Type • Abecma (idecabtagene vicleucel) • Breyanzi (lisocabtagene maraleucel) • Kymriah (tisagenlecleucel) • Tecartus (brexucabtagene autoleucel) • Yescarta (axicabtagene ciloleucel) • Carvykti (ciltacabtagene autoleucel) • Other Brands CAR T-cell Therapy Market Size & Trend Analysis, by Target Antigen • CD • BCMA • HER2 • Other Target Antigens (Other target antigens include EGFR, GD2, MUC16, Lewis Y, and ROR1) CAR T-cell Therapy Market Size & Trend Analysis, by Indication • Lymphoma • Acute Lymphoblastic Leukemia • Multiple Myeloma • Acute Myeloid Leukemia • Other Indications (Other indications include pancreatic cancer, breast cancer, ovarian cancer, scleroderma, HIV/AIDs, and autoimmune diseases.) CAR T-cell Therapy Market Size & Trend Analysis, by Geography • North America o U.S. o Canada • Europe o Germany o France o U.K. o Italy o Spain o Rest of Europe • Asia-Pacific o China o Japan o India o Rest of Asia-Pacific • Latin America • Middle East & Africa Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research (Added: Wed Mar 20 2024 Hits: 76 Rating: 0.00 Votes: 0) Rate It

• Medical Coatings Market to be Worth $3.32 Billion by 2030-Exclusive Report by Meticulous Research® - According to a new market research report, ‘Medical Coatings Market By Type (Hydrophilic, Antimicrobial, Drug-eluting, Anti-thrombogenic), Material (Polymer {Fluoropolymers, Parylene, Silicon}, Metal {Silver, Titanium}), Application (Medical Devices, Implants, Equipment) - Global Forecast to 2030', published by Meticulous Research®, the medical coatings market is projected to reach $3.32 billion by 2030, at a CAGR of 11.20% from 2023 to 2030. Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5453 Medical coatings are thin layers of material applied to medical devices, such as implants, to improve biocompatibility and reduce the risk of infection. It is essential for various medical devices, implants, and equipment to improve the device durability and patient safety. Hydrophilic coatings are commonly used to reduce friction, improve lubrication, and reduce the risk of infection in medical devices such as catheters, stents, and intraocular lenses. Further, invasive surgical instruments must have some form of antimicrobial coating to reduce the chances of infections. Major factors driving the medical coatings market are the rising incidence of healthcare associated infections (HAIs), growing adoption of minimally invasive surgical procedures, and high demand from the medical devices industry. Furthermore, the growing demand for customized and multifunctional coatings and potential in emerging economies are expected to provide significant growth opportunities for this market. However, the rising raw material prices and high costs & miniaturization of medical devices are the factors that are expected to hinder the growth of this market. Additionally, factors such as the limitations of certain types of coatings with regards to biocompatibility, lack of standardization, and durability, among others and risk of coating failure associated with the use of hydrophilic and/or hydrophobic coated medical devices are some of the major challenges for the growth of this market. The Impact of COVID-19 on the Medical Coatings Market The outbreak of the COVID-19 pandemic in March 2020 resulted in lockdowns and restrictions all over the world. During the initial stages of the global pandemic, there was a shift in focus from regular healthcare services to emergency services due to the increasing number of COVID-19 cases and the high number of hospital admissions. Hospitals worldwide postponed elective or non-emergency surgeries to prevent the risk of spreading the virus. According to a study published in the British Journal of Surgery, an estimated 28 million surgeries were canceled or postponed during the pandemic's peak. In the U.S., 91.7% of elective surgeries were canceled during April 2020, according to a survey published in the Journal of Vascular Surgery. This reduction in elective medical procedures reduced demand for medical devices, negatively impacting the medical coatings market. In addition, supply chains were disrupted, and production facilities slowed operations due to the strict lockdowns, causing delays in procuring medical devices. This caused a pronounced effect on surgical resource availability. Some companies operating in the medical coatings market also had to suspend their operation for limited periods because the employees were infected with COVID-19. These factors caused a short-term negative impact on the medical coatings market during the initial stages of the pandemic. However, as the impact of the pandemic subsided gradually, the market's growth rate is expected to normalize and reach beyond its pre-pandemic levels. Request Sample Report Here @ https://www.meticulousresearch.com/request-sample-report/cp_id=5453 The medical coatings market is segmented by Type (Hydrophilic Coatings, Antimicrobial Coatings, Drug-eluting Coatings, Anti-thrombogenic Coatings, and Other Types), Material Type [Polymers (Fluoropolymers {Polytetrafluoroethylene (PTFE), Polyvinylidene fluoride (PVDF), and Other Fluoropolymers}, Parylene, Silicones, Other Polymers), Metals (Silver, Titanium, and Other Metals), and Other Material Types], Application (Medical Devices {Neurological Devices, Cardiovascular Devices, Ophthalmology Devices, Orthopedics Devices, Dental Devices, Gynecology Devices, and Other Devices}, Medical Implants {Orthopedic Implants, Dental Implants, Cardiovascular implants, and Other Implants}, Medical Equipment & Surgical Tools, and Other Applications), and Geography. The study also evaluates industry competitors and analyzes their market share at the global and regional levels. Based on type, in 2023, the hydrophilic coatings segment is expected to account for the largest share of the medical coatings market The large market share of this segment is attributed to the high demand for hydrophilic coated medical devices such as guidewires, catheters, cannulas, and other devices due to its ability to improve the performance and maneuverability by reducing friction by imparting the necessary lubricity. This is especially important for minimally invasive procedures, which also increase in number, thus driving the market growth. Based on material type, in 2023, the polymers segment is expected to account for the largest share of the medical coatings market The large market share of this segment is attributed to factors such as the high utilization of various types of polymers for coating medical devices and equipment, advantageous properties of polymers in terms of offering better biocompatibility and inertness, and comparatively easier process of coating. Polymers are biocompatible and non-toxic, making them safe for use in medical applications. It can be used to improve the functionality of medical devices, such as reducing friction, promoting lubrication, and controlling drug delivery. Based on application, in 2023, the medical devices segment is expected to account for the largest share of the medical coatings market This segment's large market share is attributed to high medical device industry demand due to the growing adoption of minimally invasive procedures and the growing requirement to coat medical devices with a biocompatible material to prevent attrition with human tissue. In 2023, North America is expected to account for the largest share of the medical coatings market, followed by Europe and Asia-Pacific. Customize My Report @ https://www.meticulousresearch.com/request-customization/cp_id=5453 North America’s large market share is attributed to a robust healthcare industry, a large medical devices industry in the region, higher adoption of minimally invasive procedures, and increased awareness of hospital-acquired infections. The development of new medical technologies and an aging population has increased the demand for medical devices and coatings that enhance their functionality and safety. The region has a strong regulatory framework that supports the growth of the medical coatings industry and a large healthcare market. North America is also home to many leading pharmaceutical and medical device companies that invest heavily in R&D and drive innovation in the field. The report also includes an extensive assessment of the type, material type, application, and geography, and key strategic developments adopted by leading market participants in the industry over the past years (2020–2022). The medical coatings market has witnessed numerous strategic developments in recent years. The key players profiled in this market study are Hydromer Inc. (U.S.), Harland Medical Systems, Inc. (U.S.), SurModics, Inc. (U.S.), Koninklijke DSM N.V. (Netherlands), AST Products, Inc. (U.S.), Biocoat Incorporated (U.S.), Precision Coating Company, Inc (U.S.), Medicoat AG (Switzerland), Merit Medical Systems, Inc. (U.S.), and Specialty Coating Systems, Inc. (U.S.). About Meticulous Research® Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Quick Buy @ https://www.meticulousresearch.com/Checkout/16536885 The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research (Added: Wed Mar 20 2024 Hits: 58 Rating: 0.00 Votes: 0) Rate It

• Best dental clinic in Kochi - Kochi :Nechupadam Dental Clinic, a leading dental facility committed to delivering outstanding dental services, is excited to announce its grand inauguration in [Kochi, Kerala]. Upholding a standard of excellence and patient satisfaction, Nechupadam Dental Clinic provides a diverse array of dental treatments, ranging from regular cleanings to advanced procedures, ensuring optimal oral health for all individuals. Under the guidance of Dr., a proficient and seasoned dentist, the Nechupadam Dental Clinic team is devoted to offering individualised care within a friendly and inviting setting. Employing cutting-edge techniques and technology, Nechupadam Dental Clinic administers comprehensive dental services that adhere to the highest quality and safety protocols. "At Nechupadam Dental Clinic, we firmly believe that a healthy smile is crucial to overall well-being," stated Dr. The objective is to furnish each patient with top-tier care tailored to their specific requirements, aiding them in attaining and preserving optimal oral health." Nechupadam Dental Clinic provides a complete spectrum of dental services, encompassing general dentistry, cosmetic dentistry, orthodontics, and oral surgery. Whether patients necessitate a routine examination or more intricate dental procedures, the Nechupadam Dental Clinic team is dedicated to delivering compassionate care and exceptional outcomes. (Added: Wed Mar 20 2024 Hits: 57 Rating: 0.00 Votes: 0) Rate It

• Best Robotic surgeon in Kerala - Ernakulam, Kerala: With great pride, Dr. Urmila Soman announces the introduction of the Robotic Gynecologic Surgeon, a revolutionary development in the field of gynecologic surgery. This state-of-the-art technology will provide patients with a simpler, safer, and more precise surgical option, revolutionising the way complex gynecologic procedures are carried out. The Robotic Gynecologic Surgeon offers unmatched control and precision during surgery by fusing cutting-edge robotics with the knowledge of our experienced gynecologic surgeons. Compared to traditional open surgery, this cutting-edge technology enables smaller incisions, less pain and scarring, shorter hospital stays, and quicker recovery times. The Robotic Gynecologic Surgeon "represents a significant advancement in patient care, offering our patients the best possible outcomes and an improved surgical experience. We are excited to be at the forefront of gynecologic surgery." For a variety of gynecologic procedures, such as myomectomies, hysterectomies, and endometriosis resections, the Robotic Gynecologic Surgeon is the best option. Surgeons are able to execute intricate procedures with greater accuracy and dexterity in large part to their sophisticated features, which include wristed instruments and 3D visualisation. Patient satisfaction and safety are our top priorities at Dr. Urmila Soman. We are reiterating our dedication to offering our patients the best possible care and the most cutting-edge surgical options with the launch of the Robotic Gynecologic Surgeon. (Added: Tue Mar 19 2024 Hits: 93 Rating: 0.00 Votes: 0) Rate It

• Pharma and Healthcare - Remote Patient Monitoring Market - Meticulous Research®—a leading global market research company, published a research report titled, ‘Remote Patient Monitoring Market by Product ([Blood Glucose, Respiratory, Blood Pressure, Fetal, Weight Monitoring] [Wearable, Portable, Benchtop]) Application (Diabetes, Oncology, Cardiovascular, Neurological Disorders) End User - Global Forecast to 2031.’ According to this latest publication from Meticulous Research®, the global remote patient monitoring market is projected to reach $116.84 billion by 2031, at a CAGR of 13.7%. The factors driving the market are the increasing geriatric population, rising prevalence of chronic diseases, shortage of healthcare professionals, growing awareness regarding the benefits of RPM, such as convenience and improved patient outcomes, rising need to reduce healthcare costs, and favorable government initiatives promoting remote patient monitoring. Additionally, technological advancements in telehealth & remote patient monitoring, emerging economies with growing patient populations, increasing adoption of wearable devices, advancements in sensor technologies, and integration of artificial intelligence with RPM serve are expected to create market growth opportunities. To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/remote-patient-monitoring-market-5343 However, data accuracy & reliability concerns and barriers limiting the use of remote patient monitoring technologies, such as limited access and low technology literacy among patients, restrain the growth of the market. Additionally, data security & privacy concerns and increased overhead expenses due to the need for additional staff to manage the RPM system are some of the challenges impacting the market’s growth. The global remote patient monitoring market is segmented by Product (Monitoring Devices {By Functionality [Blood Glucose Monitoring, Cardiac Monitoring, Neurological Monitoring, Respiratory Monitoring, Multiparameter Monitoring, Blood Pressure Monitoring, Fetal and Neonatal Monitoring, Weight Monitoring, and Other Monitoring Devices] By Type [Wearables, Portable, and Benchtop Monitoring Devices]}, Software, Services), Application (Diabetes, Cardiovascular Diseases, Neurological Disorders, Respiratory Diseases, Oncology, Other Applications), End User (Home-care Settings, Hospitals, Long-term Care Facilities, Other End Users), and Geography. The study also evaluates industry competitors and analyzes the market at the regional and country levels. Download Sample Report Here : https://www.meticulousresearch.com/download-sample-report/cp_id=5343 Based on the product, in 2024, the monitoring devices segment is expected to account for the largest share of the market. The large share of the segment is attributed to factors such as the rising elderly population, advancements in sensor technologies, integration of artificial intelligence (AI) in monitoring devices, and the rising demand for personalized healthcare. Based on application, in 2024, the diabetes segment is expected to account for the largest share of the market. The large share of this segment is due to factors such as the utilization of telehealth, the increasing prevalence of diabetes, and the rising need to monitor diabetes patients. Based on end user, in 2024, the home-care settings segment is expected to account for the largest share of the market. The large market share of this segment is attributed to the growing shift towards home-care settings, the rising prevalence of chronic diseases among the elderly population, the shortage of healthcare professionals, and increasing consumer awareness regarding the monitoring of chronic conditions through RPM tools. Request Sample: https://www.meticulousresearch.com/request-sample-report/cp_id=5343 Geographic Review: This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, and the Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), Latin America, and the Middle East & Africa. In 2024, North America is expected to account for the largest share of the remote patient monitoring market, followed by Europe. North America’s significant market share can be attributed to factors such as the high adoption of technologically advanced products and devices, the presence of key market players, the well-established healthcare system, high consumer awareness, and high disposable incomes. Key Players: The key players profiled in the remote patient monitoring market report are Medtronic plc (Ireland), Koninklijke Philips N.V. (Netherlands), OMRON Corporation (Japan), Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), GE HealthCare Technologies, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), Baxter International, Inc. (U.S.), Oracle Corporation (U.S.), DexCom, Inc. (U.S.), and VitalConnect, Inc. (U.S.). Customize Report: https://www.meticulousresearch.com/request-customization/cp_id=5343 Key questions answered in the report- • Which are the high-growth market segments in terms of product, application, end user, and region/country? • What was the historical market for remote patient monitoring across the globe? • What are the market forecasts and estimates for the period 2024–2031? • What are the major drivers, restraints, challenges, opportunities, and trends in the global market of remote patient monitoring market? • Who are the major players in the global remote patient monitoring market? • What is the competitive landscape like, and who are the market leaders in the global remote patient monitoring market? • What are the recent developments in the remote patient monitoring market? • What are the different strategies adopted by the major players in the remote patient monitoring market? • What are the geographical trends and high growth regions/countries? Buy Now: https://www.meticulousresearch.com/Checkout/48487913 Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research (Added: Tue Mar 19 2024 Hits: 58 Rating: 0.00 Votes: 0) Rate It

•  Laboratory Water Purification Market is projected to reach $10 billion by 2030 - the lab water purification system market is projected to reach $10 billion by 2030, at a CAGR of 9.1% from 2023 to 2030. The growth of this market is attributed to factors such as rapid expansion & growth of the pharmaceutical & biotechnology industry, rising R&D expenditure of biopharmaceutical companies, growing demand for purified water in laboratories, increased focus on new drug development, and growing demand for biopharmaceuticals. In addition, the untapped market potential in emerging economies is expected to provide significant growth opportunities for this market. However, the high cost of lab water purification system is a major challenge to the growth of this market. To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/laboratory-water-purification-system-market-5430 Lab Water Purification System Market: Future Outlook The lab water purification system market is segmented by mode of use, type, application, end user, and geography. The study also evaluates industry competitors and analyzes the market at the country and regional levels. Based on mode of use, in 2023, the point of use segment is expected to account for the largest share of the lab water purification system market. The large market share of this segment is attributed to the benefits of the point-of-use system in providing a consistent supply of purified water wherever it is needed for laboratory research experiments and low chances of contamination when compared to large central systems. Download Free Sample Report Here : https://www.meticulousresearch.com/download-sample-report/cp_id=5430 Based on type, in 2023, the type 1 - ultrapure water segment is expected to account for the largest share of the lab water purification system market. The large market share of this segment is attributed to factors such as the high requirement of ultrapure water for various types of laboratory experiments and the effectiveness of ultrapure water in high-sensitivity experiments. Based on application, in 2023, the chromatography segment is expected to account for the largest share of the lab water purification system market. The large market share of this segment is attributed to the increasing requirement for a large amount of purified water for HPLC experiments and the growing applications of chromatography in the pharmaceutical industry. Based on end user, in 2023, the pharmaceutical & biotechnology companies segment is expected to account for the largest share of the lab water purification system market. The large market share of this segment is attributed to the increasing requirement of purified water in the pharma & biotech companies, the rapid expansion of the pharmaceutical & biotechnology industry in emerging economies, stringent government regulations which necessitate the use of purified water, and increased focus on research and development. Request Sample: https://www.meticulousresearch.com/request-sample-report/cp_id=5430 Geographic Review: This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, and RoE), Asia-Pacific (Japan, China, India, and RoAPAC), Latin America (Brazil, Mexico, and RoLATAM), and the Middle East & Africa. In 2023, North America is expected to account for the largest share of the global lab water purification system market, followed by Europe and Asia-Pacific. North America’s large market share is attributed to the high healthcare expenditure in the region, government regulations that push the end users to purchase lab water purification system, and the region’s robust infrastructure in sectors like pharmaceutical & biotechnology companies, academic research, and food & beverages industries. Key Players: The key players operating in the laboratory water purification system market are Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Labconco Corporation (U.S.), Evoqua Water Technologies LLC (U.S.), Veolia Water Solutions & Technologies (France) (Subsidiary of Veolia Environnement S.A. (France)), Sartorius AG (Germany), Yamato Scientific Co., Ltd. (Japan), Danaher Corporation (U.S.), Biolab Scientific Ltd. (Canada), Aqua Solutions, Inc. (U.S.), SUEZ Water Purification Systems Ltd (U.K.), NEPTEC GmbH (Germany), and RephiLe Bioscience Ltd. (U.S.). Customize Report: https://www.meticulousresearch.com/request-customization/cp_id=5430 Key questions answered in the report- • Which are the high-growth market segments in terms of mode of use, type, application, end user, and region/country? • What was the historical market size for lab water purification system across the globe? • What are the market forecasts and estimates for the period 2023–2030? • What are the major drivers, restraints, opportunities, and challenges in the global lab water purification system market? • Who are the major players in the lab water purifiers system market? • How is the competitive landscape, and who are the market leaders in the global lab water purification system market? • What are the recent developments in the global lab water purification system market? • What are the different strategies adopted by the major players in the global laboratory water purifiers market? • What are the geographical trends and high-growth regions/countries? Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research (Added: Mon Mar 18 2024 Hits: 84 Rating: 0.00 Votes: 0) Rate It

• Revolutionizing Healthcare Insights: Leading the Way with 42 market research Expertise - In an era where data-driven decisions are paramount, the healthcare industry stands at the forefront of leveraging insights to enhance patient care, optimize operations, and drive innovation. Today, we proudly announce that 42 market research is successfully operating in more than 60 countries around the world interviewing physicians, dentists, pharmacists, opticians, dietitians and other healthcare-related professionals concerning their experiences and opinions towards any health-related subject; all 100% online. As pioneers in online healthcare market research, 42 market research brings together decades of experience in advising you on who you should interview; recommended sample sizes; plus the location and demographic distributions of the study respondents to secure the most statistically viable results for your projects. “Obtaining accurate real-world results as quickly as possible is key for the pharmaceutical companies to understand and react to what is happening within the marketplace”, explains Stuart Crocker, Managing Director of 42 market research. He also added that, “42 market research is able to deliver that information by utilising our extensive network of respondents and experience that we have developed in the 22 years we have been operating.” About 42 market research 42 market research is an independent, internationally operating, market research fieldwork agency specialized purely on the healthcare sector since 2002. 42 market research is an agency member of EphMRA (European Pharmaceutical Market Research Association) and a member of the BHBIA (British Healthcare Business Intelligence Association). Contact Information 42 market research Public Relations Department P.O. Box 211791 Dubai United Arab Emirates Tel: +971 4 447 1540 Fax: +971 4 447 1542 E-Mail: press@42mr.com Website: www.42mr.com (Added: Mon Mar 18 2024 Hits: 72 Rating: 0.00 Votes: 0) Rate It

• KEVIN’S REVIEW REDESIGNED WEBSITE LAUNCHING: KEEPING US CONNECTED AND ENGAGED - Kevin’s Review, where help you prepare better for NCLEX exam by providing the comprehensive preparation programme, insightful guidance and unwavering support, today announced its new website. With this site, users can search and share knowledge directly on its interface as well as receive the fastest support from us. “Our mission is to empower nursing students worldwide, providing them with the tools, resources, and community support needed to succeed in their studies, pass the NCLEX, and excel in their nursing careers. Thus, not only academic but also every technical improvement from us is worthwhile,” said Will Milton, Chief Executive Officer at Kevin’s Review. “We’re all glad knowing that every step we take to improve our students’ experiences when they choose to log onto our system is every step we take to help them further on their career path”. As our former founder, Mr. Kevin Pan, left the team, Mr. Will Milton has continued to develop this project. This website redesign can be seen as a milestone that marks a new turning point for Kevin's Review. The new website's interface has a clean uncluttered design, improved functionally and enhanced rich content focused on NCLEX exam format to provide nurse students solution to get higher score. It goes live today, and is located at the same address: https://www.kevinsreview.com/. Users can now access our question bank, do quiz tests and engage with interactive learning tools designed to make your study sessions more effective, including flashcards, simulation exams, and video tutorials. Besides, visitors can join a supportive community of fellow nursing students and professionals to ask questions and find motivation through forums and discussion groups. In additional, we have updated to our materials bank in both quantity and quality. They are crafted and reviewed by nursing education experts, ensuring you receive up-to-date, accurate, and relevant information that aligns with the latest NCLEX standards. By accessing our new extensive library, you will effectively revise your knowledge with materials that were designed to mirror the format and difficulty of the NCLEX exam, as well as build confidence for this kind of exam in the future. "We are fascinated about our new redesigned website launch and the roburst information it provides for our students to better prepare for NCLEX exam," said Dr. Cheryl Ross, Chief Content Officer at Kevin’s Review. "We believe that this new site will allow our visitors to have very informative experiences as we continue to accelerate our academic teaching quality". For further information, please contact us through infor@kevinsreview.com. (Added: Mon Mar 18 2024 Hits: 75 Rating: 0.00 Votes: 0) Rate It

• Genetic Testing Market Size, Share Report | 2022 to 2030 - Meticulous Research®—a leading global market research company, published a research report titled, ‘Genetic Testing Market by Offering (Consumables, Reagents, Instruments, Services), Test Type (Diagnostic, Prenatal, Carrier, Newborn, Preimplantation), Method (Molecular, Chromosomal), End User (Hospitals, Diagnostic Laboratories) - Global Forecast to 2030.’ According to this latest publication from Meticulous Research®, the genetic testing market is projected to reach $28.24 billion by 2030, at a CAGR of 10.4% from 2022 to 2030. The growth of this market is mainly driven by government initiatives promoting genetic testing, the increasing prevalence of genetic disorders, a growing need for the early detection & prevention of diseases, the increasing applications of genetic testing in oncology, and the decreasing costs of sequencing procedures. However, the high cost of genetic testing in low-income countries and the social and ethical implications of genetic testing restrain the growth of the genetic testing market. The growing potential of direct-to-consumer genetic testing and the emerging field of genetic counseling are expected to create growth opportunities for the players operating in this market. However, the low chances of positive, actionable mutations and concerns regarding the security & privacy of genetic data are major challenges to market growth. To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/genetic-testing-market-5370 Genetic Testing Market: Future Outlook The genetic testing market is segmented based on offering, test type, method, end user, and geography. The study also evaluates industry competitors and analyzes the market at the country level. Based on offering, in 2023, the consumables & reagents segment is expected to account for the largest share of this market. The large market share of this segment is attributed to factors such as the recurrent use of reagents & consumables, availability of a wide range of genetic tests, recent product launches, and increased awareness about the advantages of genetic testing. Based on test type, in 2023, the prenatal testing segment is expected to account for the largest share of this market. The large market share of this segment is attributed to factors such as the growing prevalence of hereditary diseases such as cancers, Sickle Cell Disease (SCD), Cystic fibrosis (CF), Down Syndrome, neural tube defects, and inherited heart conditions, the rising demand for early disease diagnosis, and the increasing need for genetic tests to make efficient treatment decisions. Download Research Sample : https://www.meticulousresearch.com/download-sample-report/cp_id=5370 Based on method, in 2023, the molecular segment is expected to account for the largest share of this market. The large market share of this segment is attributed to its ability to detect the mutation at single nucleotide resolution with cheaper, faster, and with the utmost accuracy by using whole genome sequencing (WGS) and whole exome sequencing (WES) technology. Based on end user, in 2023, the hospitals & clinics segment is expected to account for the largest share of the market. The large market share of this segment is attributed to the high volume of genetic tests performed in hospitals & clinics and the high demand for early disease diagnosis and treatment. Geographic Review This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, and RoE), Asia-Pacific (Japan, China, India, and RoAPAC), Latin America, and the Middle East & Africa. Request for Sample: https://www.meticulousresearch.com/request-sample-report/cp_id=5370 In 2023, North America is expected to account for the largest share of the genetic testing market, followed by Europe and Asia-Pacific. North America’s large market share is attributed to high healthcare expenditure, favorable reimbursement scenario, high awareness among patients about genetic testing, and increased support and investments to enhance genome sequencing infrastructure in the region. Key Players The key players operating in the genetic testing market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), OPKO Health Inc. (U.S.), Natera, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Myriad Genetics, Inc. (U.S.), Centogene N.V. (Germany), Konica Minolta, Inc. (Japan), Fulgent Genetics, Inc. (U.S.), and Laboratory Corporation of America Holdings (U.S.). Customize Report: https://www.meticulousresearch.com/request-customization/cp_id=5370 Key questions answered in the report- • Which are the high-growth market segments in terms of offering, test type, method, end user, and region/country? • What was the historical market size for genetic testing across the globe? • What are the market forecasts and estimates for the period 2023–2030? • What are the major drivers, restraints, opportunities, and challenges in the global genetic testing market? • Who are the major players in the genetic testing market? • How is the competitive landscape, and who are the market leaders in the global genetic testing market? • What are the recent developments in the global genetic testing market? • What are the different strategies adopted by the major players in the global genetic testing market? • What are the geographical trends and high-growth regions/countries? Buy Now: https://www.meticulousresearch.com/Checkout/33822956 Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research (Added: Fri Mar 15 2024 Hits: 80 Rating: 0.00 Votes: 0) Rate It

• Best Neuro Hospital in Hyderabad - Citi Neuro Centre is a 110 bedded hospital that has been envisioned with the target of promoting neurological health, by providing international standards of clinical care along with education, research and training. Located in Banjara Hills, at the heart of Hyderabad, Citi Neuro Centre has been designed as a technologically advanced healthcare provider with a holistic approach to medicine – one that considers the healing environment. (Added: Fri Mar 15 2024 Hits: 79 Rating: 0.00 Votes: 0) Rate It

• Best Neuro Hospital in Hyderabad - Citi Neuro Centre is a 110 bedded hospital that has been envisioned with the target of promoting neurological health, by providing international standards of clinical care along with education, research and training. Located in Banjara Hills, at the heart of Hyderabad, Citi Neuro Centre has been designed as a technologically advanced healthcare provider with a holistic approach to medicine – one that considers the healing environment. (Added: Fri Mar 15 2024 Hits: 48 Rating: 0.00 Votes: 0) Rate It

Pages: [<<] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 ... [>>]